<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Genet</journal-id>
<journal-id journal-id-type="publisher-id">Front. Genet.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Genetics</journal-title>
</journal-title-group>
<issn pub-type="epub">1664-8021</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32849845</article-id>
<article-id pub-id-type="pmc">7432156</article-id>
<article-id pub-id-type="doi">10.3389/fgene.2020.00885</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Genetics</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Neurodevelopmental Disorders Caused by Defective Chromatin Remodeling: Phenotypic Complexity Is Highlighted by a Review of ATRX Function</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Timpano</surname>
<given-names>Sara</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/1030748/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Picketts</surname>
<given-names>David J.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/548941/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Regenerative Medicine Program, Ottawa Hospital Research Institute</institution>, <addr-line>Ottawa, ON</addr-line>, <country>Canada</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Biochemistry, Microbiology, and Immunology, University of Ottawa</institution>, <addr-line>Ottawa, ON</addr-line>, <country>Canada</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Cellular and Molecular Medicine, University of Ottawa</institution>, <addr-line>Ottawa, ON</addr-line>, <country>Canada</country></aff>
<aff id="aff4"><sup>4</sup><institution>Department of Medicine, University of Ottawa</institution>, <addr-line>Ottawa, ON</addr-line>, <country>Canada</country></aff>
<aff id="aff5"><sup>5</sup><institution>University of Ottawa Brain and Mind Research Institute</institution>, <addr-line>Ottawa, ON</addr-line>, <country>Canada</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Mojgan Rastegar, University of Manitoba, Canada</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Craig Peterson, University of Massachusetts Medical School, United States; Tom Moss, Laval University, Canada</p>
</fn>
<corresp id="c001">*Correspondence: David J. Picketts, <email>dpicketts@ohri.ca</email></corresp>
<fn fn-type="other" id="fn004">
<p>This article was submitted to Epigenomics and Epigenetics, a section of the journal Frontiers in Genetics</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>11</day>
<month>8</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>11</volume>
<elocation-id>885</elocation-id>
<history>
<date date-type="received">
<day>07</day>
<month>6</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>20</day>
<month>7</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2020 Timpano and Picketts.</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>Timpano and Picketts</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>The ability to determine the genetic etiology of intellectual disability (ID) and neurodevelopmental disorders (NDD) has improved immensely over the last decade. One prevailing metric from these studies is the large percentage of genes encoding epigenetic regulators, including many members of the ATP-dependent chromatin remodeling enzyme family. Chromatin remodeling proteins can be subdivided into five classes that include SWI/SNF, ISWI, CHD, INO80, and ATRX. These proteins utilize the energy from ATP hydrolysis to alter nucleosome positioning and are implicated in many cellular processes. As such, defining their precise roles and contributions to brain development and disease pathogenesis has proven to be complex. In this review, we illustrate that complexity by reviewing the roles of ATRX on genome stability, replication, and transcriptional regulation and how these mechanisms provide key insight into the phenotype of ATR-X patients.</p>
</abstract>
<kwd-group>
<kwd>intellectual disability</kwd>
<kwd>neurodevelopmental disorder</kwd>
<kwd>
<italic>ATRX</italic>
</kwd>
<kwd>ATR-X syndrome</kwd>
<kwd>chromatin remodeling</kwd>
<kwd>SWI/SNF</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">Canadian Institutes of Health Research<named-content content-type="fundref-id">10.13039/501100000024</named-content></funding-source>
<award-id rid="cn001">FRN133586</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="3"></fig-count>
<table-count count="1"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="159"></ref-count>
<page-count count="14"></page-count>
<word-count count="0"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="S1">
<title>Introduction</title>
<p>Neurodevelopmental disorders (NDD) are highly complex and heterogeneous conditions that have a global prevalence of approximately 2–3% of the population. Despite being aware of these conditions for over a century, it is only within the last decade that the development of exome and whole genome sequencing has dramatically enhanced the discovery of the underlying causes of these disorders. Indeed, the SysID database<sup><xref ref-type="fn" rid="footnote1">1</xref></sup> list 1,334 genes (updated March 26, 2020) that contribute to intellectual disability (ID) (<xref ref-type="bibr" rid="B67">Kochinke et al., 2016</xref>), while approximately 100 genes are associated with autism spectrum disorder (ASD) (<xref ref-type="bibr" rid="B117">Satterstrom et al., 2020</xref>). Interestingly, a substantial proportion of NDD causing genes are involved in chromatin and/or transcriptional regulation including the broad family of ATP-dependent chromatin remodelers.</p>
<p>Chromatin remodelers utilize energy from ATP hydrolysis to alter nucleosome spacing/density or to facilitate histone variant exchange (<xref ref-type="bibr" rid="B18">Bowman and Poirier, 2015</xref>). There are four main families of ATP-dependent chromatin remodelers characterized by their conserved ATPase domain of the helicase II superfamily (<xref ref-type="fig" rid="F1">Figure 1</xref>). These families are divided into the (1) SWI/SNF group, large complexes made up of ∼15 subunits, (2) ISWI group, heterodimers and four subunit complexes, (3) CHD group, complexes that incorporate up to ∼10 subunits, and (4) INO80 group, ∼15 subunit complexes. In addition, the focus of this review is ATRX which represents one of several orphan families that have been less studied mechanistically. In addition to the ATPase domain that is subdivided into two RecA-like lobes, these chromatin remodeling enzymes are characterized by additional motifs that facilitate protein–protein interactions (e.g., HSA and QLQ domains), DNA interactions (e.g., HAND and SLIDE domains), and chromatin interactions (e.g., SANT, chromodomain, and bromodomain) (<xref ref-type="fig" rid="F1">Figure 1</xref>). The SWI/SNF and INO80 family primarily promote transcription and DNA repair by sliding/ejecting nucleosomes (SWI/SNF/BRG1, BRM) or depositing histone variants (INO80/SRCAP). The ISWI and CHD family primarily mediate nucleosome maturation and spacing to promote chromatin formation post-replication, highly structured chromatin (ISWI), or transcriptional repression (CHD) (<xref ref-type="bibr" rid="B25">Clapier et al., 2017</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>The ATP-dependent chromatin remodeling family. Representation of the four chromatin remodeling groups: SWI/SNF, ISWI, CHD, and INO80. Each group contains an ATPase domain subdivided into RecA-like lobes 1 and 2 separated by a variable linker region (labeled insertion). SWI/SNF and INO80 share an HSA domain, while ISWI and CHD share a SANT and SLIDE domain.</p>
</caption>
<graphic xlink:href="fgene-11-00885-g001"></graphic>
</fig>
<p>Mutations in these enzyme families results in aberrant gene expression that impinges on many cellular activities including DNA replication, DNA repair, as well as cell proliferation and differentiation. As indicated above, mutations in many of these family members lead to a wide range of NDD and symptoms (<xref ref-type="table" rid="T1">Table 1</xref>) with some of the more well-studied disorders being Coffin-Siris syndrome (CSS), Nicolaides-Baraitser syndrome (NCBS), CHARGE syndrome, and ATR-X syndrome. Moreover, it is becoming clear that mutations in multiple components of these remodeling complexes cause ID (<xref ref-type="table" rid="T1">Table 1</xref>) and can contribute to a spectrum of clinical phenotypes that is best illustrated by mutations in the SWI/SNF interacting partners (<xref ref-type="bibr" rid="B17">Bögershausen and Wollnik, 2018</xref>; <xref ref-type="bibr" rid="B139">van der Sluijs et al., 2019</xref>). The reader is referred to a number of recent reviews for detailed information of these different remodeler classes (<xref ref-type="bibr" rid="B58">Hota and Bruneau, 2016</xref>; <xref ref-type="bibr" rid="B125">Sokpor et al., 2017</xref>; <xref ref-type="bibr" rid="B44">Goodwin and Picketts, 2018</xref>; <xref ref-type="bibr" rid="B3">Alfert et al., 2019</xref>; <xref ref-type="bibr" rid="B53">Hoffmann and Spengler, 2019</xref>).</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>ATP-dependent chromatin remodelers are a frequent cause of NDDs. List of NDD implicated genes which are incorporated into ATP-dependent chromatin remodeling complexes.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Family</td>
<td align="left" colspan="1" rowspan="1" valign="top">Gene</td>
<td align="left" colspan="1" rowspan="1" valign="top">Associated disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">References</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SWI/SNF</td>
<td align="left" colspan="1" rowspan="1" valign="top">ARID1A</td>
<td align="left" colspan="1" rowspan="1" valign="top">ID, CSS</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B136">Tsurusaki et al. (2012)</xref>; <xref ref-type="bibr" rid="B68">Kosho et al. (2013)</xref></td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">ARID1B</td>
<td align="left" colspan="1" rowspan="1" valign="top">ID, CSS, ASD</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B60">Hoyer et al. (2012)</xref>; <xref ref-type="bibr" rid="B114">Santen et al. (2012)</xref>; <xref ref-type="bibr" rid="B28">De Rubeis et al. (2014)</xref></td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">ARID2</td>
<td align="left" colspan="1" rowspan="1" valign="top">ID, CSS-like, NCBS-like</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B121">Shang et al. (2015)</xref>; <xref ref-type="bibr" rid="B19">Bramswig et al. (2017)</xref></td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">DPF2</td>
<td align="left" colspan="1" rowspan="1" valign="top">ID, CSS-like</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B142">Vasileiou et al. (2018)</xref>
</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">PBRM</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B98">O’Roak et al. (2012b)</xref>
</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">SMARCA2</td>
<td align="left" colspan="1" rowspan="1" valign="top">NCBS</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B140">Van Houdt et al. (2012)</xref>; <xref ref-type="bibr" rid="B135">Tsurusaki et al. (2014b)</xref></td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">SMARCB1</td>
<td align="left" colspan="1" rowspan="1" valign="top">ID, CSS, Kleefstra</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B66">Kleefstra et al. (2012)</xref>; <xref ref-type="bibr" rid="B115">Santen et al. (2013)</xref>; <xref ref-type="bibr" rid="B150">Wieczorek et al. (2013)</xref></td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">SMARCC1</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B57">Hormozdiari et al. (2015)</xref>
</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">SMARCC2</td>
<td align="left" colspan="1" rowspan="1" valign="top">ID, ASD</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B85">Machol et al. (2019)</xref>
</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">SMARCE1</td>
<td align="left" colspan="1" rowspan="1" valign="top">CSS-like</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B136">Tsurusaki et al. (2012)</xref>; <xref ref-type="bibr" rid="B68">Kosho et al. (2013)</xref>; <xref ref-type="bibr" rid="B150">Wieczorek et al. (2013)</xref></td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">SMARCA4</td>
<td align="left" colspan="1" rowspan="1" valign="top">CSS</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B115">Santen et al. (2013)</xref>; <xref ref-type="bibr" rid="B135">Tsurusaki et al. (2014b)</xref></td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">SOX11</td>
<td align="left" colspan="1" rowspan="1" valign="top">ID, CSS-like</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B134">Tsurusaki et al. (2014a)</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ISWI</td>
<td align="left" colspan="1" rowspan="1" valign="top">BAZ1A</td>
<td align="left" colspan="1" rowspan="1" valign="top">ID</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B158">Zaghlool et al. (2016)</xref>
</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">BAZ1B</td>
<td align="left" colspan="1" rowspan="1" valign="top">Williams-Beuren syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B84">Lu et al. (1998)</xref>; <xref ref-type="bibr" rid="B100">Peoples et al. (1998)</xref></td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">BAZ2B</td>
<td align="left" colspan="1" rowspan="1" valign="top">ID, ASD</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B120">Scott et al. (2020)</xref>
</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">BPTF</td>
<td align="left" colspan="1" rowspan="1" valign="top">ID</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B128">Stankiewicz et al. (2017)</xref>
</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">SMARCA1</td>
<td align="left" colspan="1" rowspan="1" valign="top">CSS-like, Rett syndrome-like, schizophrenia</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B65">Karaca et al. (2015)</xref>; <xref ref-type="bibr" rid="B55">Homann et al. (2016)</xref>; <xref ref-type="bibr" rid="B80">Lopes et al. (2016)</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">CHD</td>
<td align="left" colspan="1" rowspan="1" valign="top">CHD2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lennox-Gastaut syndrome, Doose Syndrome, Epileptic encephalopathy</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B23">Carvill et al. (2013)</xref>
</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">CHD3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Macrocephaly, ID, impaired speech/language</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B124">Snijders Blok et al. (2018)</xref>
</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">CHD4</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sifrim–Hitz–Weiss syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B149">Weiss et al. (2020)</xref>
</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">CHD5</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD-like</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B105">Pisansky et al. (2017)</xref>
</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">CHD7</td>
<td align="left" colspan="1" rowspan="1" valign="top">CHARGE syndrome, ASD</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B144">Vissers et al. (2004)</xref>; <xref ref-type="bibr" rid="B113">Sanlaville et al. (2006)</xref>; <xref ref-type="bibr" rid="B98">O’Roak et al. (2012b)</xref></td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">CHD8</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B97">O’Roak et al. (2012a</xref>, <xref ref-type="bibr" rid="B98">b)</xref>; <xref ref-type="bibr" rid="B28">De Rubeis et al. (2014)</xref>; <xref ref-type="bibr" rid="B92">Neale et al. (2016)</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">INO80</td>
<td align="left" colspan="1" rowspan="1" valign="top">INO80</td>
<td align="left" colspan="1" rowspan="1" valign="top">Microcephaly, ID</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B2">Alazami et al. (2015)</xref>
</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">SRCAP</td>
<td align="left" colspan="1" rowspan="1" valign="top">Floating-harbor syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B56">Hood et al. (2012)</xref>
</td>
</tr>
<tr>
<td align="justify" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">YY1AP1</td>
<td align="left" colspan="1" rowspan="1" valign="top">ID</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B47">Guo et al. (2017)</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ATRX</td>
<td align="left" colspan="1" rowspan="1" valign="top">ATRX</td>
<td align="left" colspan="1" rowspan="1" valign="top">ATR-X syndrome</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B41">Gibbons et al. (1995)</xref>
</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Here, we will review recent studies on ATRX to highlight the multiple biochemical functions chromatin remodeling proteins participate in, and the diverse set of mechanisms that, collectively, contribute to the complexity underlying the pathogenesis of NDD.</p>
</sec>
<sec id="S2">
<title>Molecular Genetics of the ATR-X Syndrome</title>
<p>The ATR-X syndrome is a rare human congenital disorder with a wide range of symptoms that primarily affects males. Over 200 cases have been identified worldwide with and an estimated prevalence of &lt;1–9/1,000,000 (<xref ref-type="bibr" rid="B39">Gibbons, 2006</xref>). Affected individuals display cognitive impairment typically described as severe ID, and many are non-verbal, capable of speaking or signing only a few words (<xref ref-type="bibr" rid="B118">Saugier-Veber et al., 1995</xref>; <xref ref-type="bibr" rid="B45">Guerrini et al., 2000</xref>). Originally, the presence of alpha thalassemia was used as a diagnostic tool to identify affected individuals, but there is variability in the hematological symptoms (<xref ref-type="bibr" rid="B41">Gibbons et al., 1995</xref>). The majority of patients are affected with microcephaly and skeletal malformations (<xref ref-type="bibr" rid="B54">Holmes and Gang, 1984</xref>; <xref ref-type="bibr" rid="B22">Carpenter et al., 1999</xref>). Muscle development is also impaired in most, leading to delayed motor development and hypotonia, while approximately one third of patients experience seizures (<xref ref-type="bibr" rid="B81">Lossi et al., 1999</xref>).</p>
<p>Although ATR-X syndrome patients present with a heterogeneous phenotype, the disease is caused by mutations in a single gene, the <italic>ATRX</italic> locus, which spans over 300 kbp on chromosome Xq13.3-21.1 (<xref ref-type="bibr" rid="B41">Gibbons et al., 1995</xref>, <xref ref-type="bibr" rid="B42">2008</xref>; <xref ref-type="bibr" rid="B103">Picketts et al., 1996</xref>). The <italic>ATRX</italic> gene encodes two major trasncripts (<xref ref-type="fig" rid="F2">Figure 2</xref>), one encoding the full length protein and a truncated isoform generated by an alternative splicing event that retains intron 11 and terminates translation prematurely (<xref ref-type="bibr" rid="B36">Garrick et al., 2004</xref>; <xref ref-type="bibr" rid="B90">Mitson et al., 2011</xref>). The full length transcript encodes a protein of 285 kDa in size while the shorter transcript generates a smaller truncated protein that is 180 kDa and lacks the ATP-dependent remodeling domain (<xref ref-type="bibr" rid="B103">Picketts et al., 1996</xref>; <xref ref-type="bibr" rid="B36">Garrick et al., 2004</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>ATRX domain structure. Schematic diagram of full-length ATRX (282 kDa), truncated ATRX (ATRXt; 180 kDa), and locations of the key protein interaction domains. The two isoforms share an ADD domain, a HP1α binding motif, an EZH2 binding motif, while the ADD domain is comprised of a GATA-like zinc finger and a PHD-like zinc finger. The full-length polypeptide also contains a DAXX binding motif, a SNF2-ATPase domain comprising RecA-like lobes 1 and 2 separated by a linker region containing a MeCP2 binding motif (MeCP2/Insertion), and a PML targeting motif.</p>
</caption>
<graphic xlink:href="fgene-11-00885-g002"></graphic>
</fig>
<p>The <italic>N</italic>-terminus of the ATRX protein houses several motifs critical for its interaction with chromatin, including a heterochromatin protein 1 (HP1α) binding motif (PxVxL) (<xref ref-type="bibr" rid="B73">Lechner et al., 2005</xref>) and enhancer of zeste homolog 2 (EZH2) interaction domain (<xref ref-type="bibr" rid="B21">Cardoso et al., 1998</xref>), and the ATRX-DNMT3-DNMT3L (ADD) domain (<xref ref-type="bibr" rid="B104">Picketts et al., 1998</xref>; <xref ref-type="bibr" rid="B154">Xie et al., 1999</xref>). The ADD domain comprises a GATA-like zinc finger and a plant homeodomain (PHD)-like finger that targets the dual histone post translational modification (PTM), H3K9me3 and H3K4me0 (<xref ref-type="bibr" rid="B6">Argentaro et al., 2007</xref>; <xref ref-type="bibr" rid="B30">Dhayalan et al., 2011</xref>; <xref ref-type="bibr" rid="B35">Eustermann et al., 2011</xref>; <xref ref-type="bibr" rid="B63">Iwase et al., 2011</xref>). A region within the center of the polypeptide mediates death domain associated protein (DAXX) binding (<xref ref-type="bibr" rid="B155">Xue et al., 2003</xref>). Toward the <italic>C</italic>-terminus lies the highly conserved RecA-like lobes 1 and 2 that together are required for ATPase activity (<xref ref-type="bibr" rid="B103">Picketts et al., 1996</xref>), as well as mapped regions for interactions with the methyl-CpG-binding protein (MeCP2) (<xref ref-type="bibr" rid="B91">Nan et al., 2007</xref>) and the promyelocytic leukemia protein (PML) (<xref ref-type="bibr" rid="B12">Bérubé et al., 2008</xref>) (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p>
<p>The majority of ATR-X syndrome causing mutations are missense mutations mapping within the ADD (50%) and SNF2-like/helicase domains (30%) (<xref ref-type="bibr" rid="B6">Argentaro et al., 2007</xref>; <xref ref-type="bibr" rid="B42">Gibbons et al., 2008</xref>). To date, there has been a lack of genotype: phenotype correlations identified, although mutations within the ADD domain typically produce more severe psychomotor phenotypes compared to mutations in the SNF2-like/helicase domain (<xref ref-type="bibr" rid="B8">Badens et al., 2006</xref>).</p>
<p>It should also be noted that somatic mutations in the <italic>ATRX</italic> gene have been identified in a wide range of cancers that include pancreatic neuroendocrine tumors, gliomas, neuroblastomas, and sarcomas, which will not be discussed here but have been the focus of recent reviews (<xref ref-type="bibr" rid="B147">Watson et al., 2015</xref>; <xref ref-type="bibr" rid="B32">Dyer et al., 2017</xref>).</p>
</sec>
<sec id="S3">
<title>Interacting Partners and Biochemical Functions</title>
<p>All functional studies indicate that ATRX is a heterochromatin interacting protein. It localizes to pericentromeric heterochromatin, telomeres, PML nuclear bodies, and physically interacts with the HP1 family (<xref ref-type="bibr" rid="B88">McDowell et al., 1999</xref>; <xref ref-type="bibr" rid="B15">Berube et al., 2000</xref>; <xref ref-type="bibr" rid="B131">Tang et al., 2004</xref>). Later work demonstrated that ATRX could be recruited to the heterochromatin histone mark, H3K9me3, either indirectly by its interaction with HP1 or recruitment by MeCP2, and directly by binding of the ADD domain to H3K9me3 that lies adjacent to unmethylated H3K4 (<xref ref-type="bibr" rid="B15">Berube et al., 2000</xref>; <xref ref-type="bibr" rid="B10">Bannister et al., 2001</xref>; <xref ref-type="bibr" rid="B91">Nan et al., 2007</xref>; <xref ref-type="bibr" rid="B35">Eustermann et al., 2011</xref>; <xref ref-type="bibr" rid="B63">Iwase et al., 2011</xref>). ATRX and DAXX were identified as interacting partners by two separate groups, one using ATRX co-IP experiments and the other a Flag-DAXX pull-down approach (<xref ref-type="bibr" rid="B155">Xue et al., 2003</xref>; <xref ref-type="bibr" rid="B131">Tang et al., 2004</xref>). Further characterization showed that most of the endogenous ATRX protein is in a 1 MDa complex with DAXX, while DAXX also fractionates in a 700 kDa complex independent of ATRX. Deletion mutants were used to demonstrate that the ATRX/DAXX interaction was mediated through the PAH domain of DAXX and a region between the ADD and SNF2 domains within ATRX (<xref ref-type="bibr" rid="B131">Tang et al., 2004</xref>). Both the ATRX/DAXX complex and recombinant ATRX protein had DNA or nucleosome stimulated ATPase activity which was impaired by patient mutations that localized to the ATPase domain (<xref ref-type="bibr" rid="B155">Xue et al., 2003</xref>; <xref ref-type="bibr" rid="B131">Tang et al., 2004</xref>). A mononucleosome disruption assay was used to demonstrate that the ATRX/DAXX complex could alter the DNAse I digestion pattern of the mononucleosome in the presence of ATP. The localization of the altered digestion pattern indicated that ATRX/DAXX disrupts DNA–histone interactions at the entry site of the nucleosome and does not alter nucleosome phasing. In addition, a triple-helix strand displacement assay was used to show that the ATRX/DAXX complex and ATRX alone had a DNA translocase property similar to the RSC and SWI/SNF complexes (<xref ref-type="bibr" rid="B155">Xue et al., 2003</xref>). More recent work has indicated that DAXX is an H3.3-specific histone chaperone that functions with ATRX to deposit the histone variant at pericentric and telomeric repeats, while DAXX functions independently of ATRX to repress retrotransposons (<xref ref-type="bibr" rid="B79">Lewis et al., 2010</xref>; <xref ref-type="bibr" rid="B52">Hoelper et al., 2017</xref>). In this regard, the ATRX/DAXX complex shows some similarities with the ISWI complex ACF and its interactions with the histone chaperone NAP1 (<xref ref-type="bibr" rid="B38">Gemmen et al., 2005</xref>; <xref ref-type="bibr" rid="B132">Torigoe et al., 2011</xref>). These properties could be used to reconstitute H3.3 containing nucleosomal arrays that might guide future <italic>in vitro</italic> biochemical studies to further define ATRX function during transcription or DNA replication (<xref ref-type="bibr" rid="B101">Peterson, 2009</xref>).</p>
<p>Indeed, in a series of papers ATRX, DAXX, and the histone variant H3.3 were shown to co-localize at telomeres where the ATRX/DAXX complex functions as a histone chaperone to deposit H3.3 into telomeric heterochromatin (<xref ref-type="bibr" rid="B152">Wong et al., 2009</xref>; <xref ref-type="bibr" rid="B43">Goldberg et al., 2010</xref>; <xref ref-type="bibr" rid="B79">Lewis et al., 2010</xref>). Further work showed that DAXX functions as the histone chaperone, that H3.3K9me3 deposition occurs in a replication-independent manner by the complex, and both H3.3 loading and heterochromatin organization by ATRX/DAXX is mediated by SUV39H1 and PML in PML-associated heterochromatin domains (<xref ref-type="bibr" rid="B31">Drané et al., 2010</xref>; <xref ref-type="bibr" rid="B43">Goldberg et al., 2010</xref>; <xref ref-type="bibr" rid="B79">Lewis et al., 2010</xref>; <xref ref-type="bibr" rid="B49">He et al., 2015</xref>; <xref ref-type="bibr" rid="B137">Udugama et al., 2015</xref>; <xref ref-type="bibr" rid="B29">Delbarre et al., 2017</xref>). Additionally, ATRX was shown to be critical for the formation of senescence-induced heterochromatin foci (SAHF) that help drive cancer cells into therapy-induced senescence (<xref ref-type="bibr" rid="B69">Kovatcheva et al., 2017</xref>). Finally, ATRX has been shown to bind to the <italic>Xist</italic> lncRNA to promote recruitment of the PRC2 repressive complex and facilitate stable heterochromatin formation of the silenced X-chromosome (<xref ref-type="bibr" rid="B116">Sarma et al., 2014</xref>). RNA binding remains an understudied role for ATRX, although several reports have shown a range of interactions with multiple lncRNAs including TERRA (telomeric repeat-containing RNA) (<xref ref-type="bibr" rid="B24">Chu et al., 2017</xref>; <xref ref-type="bibr" rid="B93">Nguyen et al., 2017</xref>), <italic>ChRO1</italic> in muscle (<xref ref-type="bibr" rid="B99">Park et al., 2018</xref>), and minor satellite RNAs at centromeric heterochromatin (<xref ref-type="bibr" rid="B106">Ren et al., 2020</xref>). These interactions are mediated through a unique <italic>N</italic>-terminal domain in ATRX to regulate differentiation, gene expression, DNA and histone methylation and chromatin compaction (<xref ref-type="bibr" rid="B24">Chu et al., 2017</xref>; <xref ref-type="bibr" rid="B93">Nguyen et al., 2017</xref>; <xref ref-type="bibr" rid="B99">Park et al., 2018</xref>; <xref ref-type="bibr" rid="B106">Ren et al., 2020</xref>).</p>
<p>A role for ATRX at heterochromatin was also strengthened by chromatin immunoprecipitation experiments that showed enriched ATRX binding at telomeres and centromeres. Interestingly, ATRX was also enriched at repetitive DNA elements while having a lower frequency of binding within gene bodies (<xref ref-type="bibr" rid="B72">Law et al., 2010</xref>). Further characterization showed that ATRX was prevalent at long terminal repeats of endogenous retrovirus sequences of family K (ERVK), at variable number tandem repeats (VNTRs) and at simple tandem repeats (<xref ref-type="bibr" rid="B72">Law et al., 2010</xref>). Many of the tandem repeats were GC-rich sequences that are predicted to form G-quadruplex secondary DNA structures (G4 DNA) including the telomeric repeats and some CpG islands. The formation of G4 DNA has been proposed to have important roles in the regulation of gene expression, as well as be prohibitive to DNA replication and transcription (<xref ref-type="bibr" rid="B107">Rhodes and Lipps, 2015</xref>; <xref ref-type="bibr" rid="B138">Valton and Prioleau, 2016</xref>; <xref ref-type="bibr" rid="B141">Varshney et al., 2020</xref>). <italic>In vitro</italic> studies confirmed that ATRX can bind to G4 DNA structures (<xref ref-type="bibr" rid="B72">Law et al., 2010</xref>). In addition, ATRX mutations have variable effects on α-globin expression including individuals with the same mutation. <xref ref-type="bibr" rid="B72">Law et al. (2010)</xref> demonstrate that one ATRX binding site lies within a GC-rich VNTR sequence 1 kb upstream of the HBM gene. The authors demonstrate a positive correlation in ATR-X patients such that increasing VNTR repeat size increases the severity of the α-thalassemia as measured by the level of HbH inclusions in red blood cells. Since the sequence is a GC-rich VNTR that is predicted to form G4 quadruplexes, it was inferred that increasing repeat size increases the probability to form G4 DNA that subsequently alters HBM expression.</p>
<p>The ATRX protein was also shown to co-purify with the MRE11-RAD50-NBS1 (MRN) complex, an active player in the processing of DNA double strand breaks (DSB) that suggested ATRX was critical to maintain genome integrity (<xref ref-type="bibr" rid="B76">Leung et al., 2013</xref>). Consistent with this finding, ATRX knockdown studies in HeLa cells resulted in defects in mitotic progression and micronuclei formation from altered chromosome condensation and centromeric cohesion (<xref ref-type="bibr" rid="B109">Ritchie et al., 2008</xref>). Other studies indicated that ATRX loss impaired replication fork progression during S-phase resulting in telomere fragility, increased DSB, and mitotic catastrophe (<xref ref-type="bibr" rid="B62">Huh et al., 2012</xref>, <xref ref-type="bibr" rid="B61">2016</xref>; <xref ref-type="bibr" rid="B76">Leung et al., 2013</xref>; <xref ref-type="bibr" rid="B148">Watson et al., 2013</xref>).</p>
<p>The ATRX-DAXX-H3.3 complex is critical for this heterochromatic formation and subsequent maintenance (<xref ref-type="bibr" rid="B72">Law et al., 2010</xref>; <xref ref-type="bibr" rid="B33">Eid et al., 2015</xref>; <xref ref-type="bibr" rid="B49">He et al., 2015</xref>; <xref ref-type="bibr" rid="B137">Udugama et al., 2015</xref>). H3.3 within telomeric regions is targeted for trimethylation on its K9 residue (<xref ref-type="bibr" rid="B49">He et al., 2015</xref>; <xref ref-type="bibr" rid="B137">Udugama et al., 2015</xref>). H3.3K9me3 recruits more ATRX-DAXX-H3.3 complexes, which in turn will deposit H3.3, creating a positive feedback loop required for maintaining telomere structure (<xref ref-type="bibr" rid="B137">Udugama et al., 2015</xref>). Failure to establish proper structure will reduce telomere integrity and result in an increase of non-coding telomeric transcript expression (<xref ref-type="bibr" rid="B49">He et al., 2015</xref>; <xref ref-type="bibr" rid="B137">Udugama et al., 2015</xref>).</p>
<p>The eclectic properties of the ATRX protein do not make it intuitively obvious how an aberration of these functions can result in a neurodevelopment disorder with cognitive deficits. In the remaining section, we discuss the characterization of mouse models and the insights they have provided into the pathophysiology of ATR-X patients and, more generally, the complex etiology of NDDs caused by defective epigenetic regulators.</p>
</sec>
<sec id="S4">
<title>Delineating Pathophysiological Mechanisms of the ATR-X Syndrome</title>
<sec id="S4.SS1">
<title>Functional Effects of Patient Mutations and Generation of Animal Models</title>
<p>One of the first questions addressed was do patient mutations affect protein stability and function? Immunoblots of extracts from patient-derived EBV-transformed B-lymphocytes showed significantly reduced levels of ATRX protein from all patients tested (<xref ref-type="bibr" rid="B88">McDowell et al., 1999</xref>; <xref ref-type="bibr" rid="B20">Cardoso et al., 2000</xref>). Interestingly, in patients with early premature stop codons (e.g., p.Arg37X), translation was initiated from an internal methionine that produced a smaller truncated protein at ∼30% levels leading to a milder phenotype (<xref ref-type="bibr" rid="B59">Howard et al., 2004</xref>; <xref ref-type="bibr" rid="B1">Abidi et al., 2005</xref>; <xref ref-type="bibr" rid="B11">Basehore et al., 2015</xref>). Utilizing recombinant proteins, other studies demonstrated that mutations within the ATPase domain attenuated ATPase activity but did not reduce it, while mutations in the ADD domain or the PML-targeting domain reduced localization to chromocenters and PML nuclear bodies, respectively (<xref ref-type="bibr" rid="B20">Cardoso et al., 2000</xref>; <xref ref-type="bibr" rid="B12">Bérubé et al., 2008</xref>). <italic>Atrx</italic>-null mutations in mice show defective extraembryonic trophoblast development and die embryonically at ∼E9.5 (<xref ref-type="bibr" rid="B37">Garrick et al., 2006</xref>). Collectively, these studies indicate that ATR-X syndrome causing mutations are functional hypomorphs, while more severe mutations are not found and are presumably non-viable.</p>
<p>Several different ATRX-deficient mouse lines have been generated and used for functional characterization. The most widely used model is a floxed allele in which loxP sites flanked exon 18 which encodes the ATP-binding pocket (<xref ref-type="bibr" rid="B14">Bérubé et al., 2005</xref>; <xref ref-type="bibr" rid="B37">Garrick et al., 2006</xref>). These animals have been crossed with several different tissue-specific Cre driver lines to inactivate ATRX in skeletal muscle progenitors (<xref ref-type="bibr" rid="B62">Huh et al., 2012</xref>), Sertoli cells (<xref ref-type="bibr" rid="B9">Bagheri-fam et al., 2011</xref>), osteobalsts (<xref ref-type="bibr" rid="B127">Solomon et al., 2013</xref>), chondrocytres (<xref ref-type="bibr" rid="B126">Solomon et al., 2009</xref>), the retina (<xref ref-type="bibr" rid="B89">Medina et al., 2009</xref>; <xref ref-type="bibr" rid="B70">Lagali et al., 2016</xref>), and the developing forebrain (<xref ref-type="bibr" rid="B14">Bérubé et al., 2005</xref>) among others. A second transgenic line (<italic>Atrx<sup>Δ<italic>E</italic>2</sup></italic>) was developed by deleting exon 2 and replacing it with a SA-IRES-β-geo cassette (<xref ref-type="bibr" rid="B95">Nogami et al., 2011</xref>; <xref ref-type="bibr" rid="B122">Shioda et al., 2011</xref>). This mutation was meant to mimic the p.Arg37X mutation and make an <italic>N</italic>-terminally truncated ATRX protein by initiating translation from an internal methionine codon (<xref ref-type="bibr" rid="B59">Howard et al., 2004</xref>; <xref ref-type="bibr" rid="B1">Abidi et al., 2005</xref>). Both of these models will be discussed in more detail in the following sections. Finally, an overexpression transgenic line was created with the <italic>ATRX</italic> cDNA under control of a CMV enhancer/β-actin promoter which resulted in growth retardation, neural tube defects and a high incidence of embryonic lethality demonstrating the importance of ATRX dosage to normal development (<xref ref-type="bibr" rid="B13">Berube et al., 2002</xref>).</p>
<p>While each of these models has provided valuable insight into disease mechanisms (as highlighted below), the field still awaits a model whereby a single nucleotide variant is introduced into the <italic>ATRX</italic> gene to recreate a known patient mutation, such as the common p.Arg246Cys mutation within the ADD domain.</p>
</sec>
<sec id="S4.SS2">
<title>Replication Stress Impairs Progenitor Expansion Resulting in Microcephaly</title>
<p>Microcephaly is common to many NDDs and has also been observed in mouse models that deleted other genes encoding chromatin remodeling proteins (<xref ref-type="bibr" rid="B111">Ronan et al., 2013</xref>). Most ATR-X patients develop postnatal microcephaly and, in instances where CT or MRI scans have been performed, mild cerebral atrophy was detected. Similarly, three patient autopsy reports also described that the brains were smaller in size (<xref ref-type="bibr" rid="B39">Gibbons, 2006</xref>).</p>
<p>The first indication that ATRX may be critical for cell growth came from co-culture experiments of embryonic stem cells (ESC) from control or <italic>Atrx</italic>-null cells. This experiment demonstrated that the <italic>Atrx</italic>-null cells were underrepresented after 4-days of co-culture. Flow cytometry was used to examine cell cycle distribution but no differences were observed suggesting that cells may have transitioned to a slower cycling, differentiated cell type (<xref ref-type="bibr" rid="B37">Garrick et al., 2006</xref>). Given that ATRX has high expression in the developing forebrain, the <italic>Atrx</italic><sup><italic>fl/fl</italic></sup> line was next crossed with the forebrain-specific Foxg1-Cre line (<italic>Atrx<sup><italic>Foxg</italic>1<italic>Cre</italic></sup></italic>) that initiates Cre expression in the developing telencephalon at ∼E8.5 (<xref ref-type="bibr" rid="B51">Hébert and McConnell, 2000</xref>). Loss of ATRX caused a 25–30% reduction in cell number with a noticeably smaller neocortex and hippocampus including almost a complete absence of the dentate gyrus that likely contributed to early postnatal lethality (<xref ref-type="bibr" rid="B14">Bérubé et al., 2005</xref>). Similar to ESC co-culture experiments, BrdU-pulse labeling experiments suggested no differences in the proportion of cycling cells. However, there was a dramatic increase in the number of TUNEL+ cells leading to a reduction in the number of neurons that reached the cortical layers (<xref ref-type="bibr" rid="B14">Bérubé et al., 2005</xref>). Similarily, the <italic>Atrx<sup>Δ<italic>E</italic>2</sup></italic> mice were smaller and also showed brain hypocellularity, although to a milder extent (<xref ref-type="bibr" rid="B95">Nogami et al., 2011</xref>). <italic>Atrx</italic> inactivation in Sertoli and muscle cells, also showed a significant impact on the growth of the tissue (<xref ref-type="bibr" rid="B9">Bagheri-fam et al., 2011</xref>; <xref ref-type="bibr" rid="B62">Huh et al., 2012</xref>). However, a retina progenitor cell cKO only had a limited effect on the size of the mature tissue suggesting that defects in cell cycle progression lead to significant hypocellularity among tissues that require a rapid expansion over a narrow developmental timeframe (<xref ref-type="bibr" rid="B89">Medina et al., 2009</xref>).</p>
<p>Although not initially observed, delayed cell cycle progression through both S- and G2/M phases was later observed in other studies (<xref ref-type="bibr" rid="B109">Ritchie et al., 2008</xref>; <xref ref-type="bibr" rid="B148">Watson et al., 2013</xref>; <xref ref-type="bibr" rid="B61">Huh et al., 2016</xref>). For G2/M, the progression from prometaphase to metaphase was prolonged and associated with sister chromatid cohesion and congression defects that impaired proper separation at anaphase leading to DNA bridges and micronuclei (<xref ref-type="bibr" rid="B109">Ritchie et al., 2008</xref>). Evidence for DNA bridges and micronuclei in <italic>Atrx<sup><italic>Foxg</italic>1<italic>Cre</italic></sup></italic> mice were also detected by high magnification microscopy at the apical surface on cortical sections of the neuroepithelium where cortical progenitors complete mitosis. Interestingly, a recent study has also demonstrated that ATRX promotes telomere cohesion between sister telomeres to mediate the repair of DNA DSB (<xref ref-type="bibr" rid="B83">Lovejoy et al., 2020</xref>).</p>
<p>Defects in S-phase were observed using BrdU-pulse chase flow cytometry experiments where a delay from G1 to S-phase and also from G2/M to the following G1 phase was identified (<xref ref-type="bibr" rid="B62">Huh et al., 2012</xref>). Co-labeling experiments demonstrated that ATRX associated with replicating chromatin during mid-late S-phase and cytological analysis showed a high prevalence of genomic instability that was enriched at telomeres and pericentromeric heterochromatin (<xref ref-type="bibr" rid="B62">Huh et al., 2012</xref>; <xref ref-type="bibr" rid="B148">Watson et al., 2013</xref>). Moreover, treatment with a compound that binds and stabilizes G4 DNA increased the number of telomere dysfunction induced foci (TIFs) and decreased cell viability suggesting that G4 DNA formation was the main cause of replicative stress (<xref ref-type="bibr" rid="B148">Watson et al., 2013</xref>). Other studies indicate that replication stress at telomeres may be mediated by increased TERRA transcription (<xref ref-type="bibr" rid="B93">Nguyen et al., 2017</xref>). TERRA levels are tightly regulated and critical for both telomere formation, replication and maintenance (<xref ref-type="bibr" rid="B16">Bettin et al., 2019</xref>). However, when TERRA levels increase, as shown for ATRX-null cells, it enhances R-loop (RNA-DNA hybrid) formation and G4 DNA stabilization, each of which increase replication fork stalling and collapse that then induces homology directed repair (HDR) and TIFs (<xref ref-type="bibr" rid="B93">Nguyen et al., 2017</xref>). The regulation of R-loops has also been proposed for other proteins that interact with G4 DNA during replication and/or at telomeres (<xref ref-type="bibr" rid="B159">Zhou et al., 2014</xref>; <xref ref-type="bibr" rid="B108">Ribeiro de Almeida et al., 2018</xref>; <xref ref-type="bibr" rid="B133">Toubiana and Selig, 2018</xref>; <xref ref-type="bibr" rid="B86">Maffia et al., 2020</xref>). It should also be mentioned here that somatic <italic>ATRX</italic> mutations, and to a lesser extent H3.3 and DAXX mutations, are prevalent in cancers characterized by ALT (alternative lengthening of telomeres), a HDR mechanism to maintain telomere length that is normally suppressed by ATRX (<xref ref-type="bibr" rid="B50">Heaphy et al., 2011</xref>; <xref ref-type="bibr" rid="B82">Lovejoy et al., 2012</xref>; <xref ref-type="bibr" rid="B119">Schwartzentruber et al., 2012</xref>; <xref ref-type="bibr" rid="B102">Pickett and Reddel, 2015</xref>; <xref ref-type="bibr" rid="B143">Verma and Greenberg, 2016</xref>).</p>
<p>Another indicator of replicative stress as a major impediment to growth of <italic>Atrx</italic>-null cells was demonstrated by studies showing an increased sensitivity to hydroxyurea, enhanced DSBs, and the use of DNA fiber analysis to show increased stalled replication forks and reduced origin firing (<xref ref-type="bibr" rid="B76">Leung et al., 2013</xref>; <xref ref-type="bibr" rid="B26">Clynes et al., 2014</xref>; <xref ref-type="bibr" rid="B61">Huh et al., 2016</xref>). Mechanistically, ATRX physically interacts with the MRN complex where it is thought to block HDR at stalled replication forks to allow for fork restart after the G4 DNA is resolved (<xref ref-type="bibr" rid="B26">Clynes et al., 2014</xref>). Indeed, one group demonstrated that fork protection could be restored by treatment with an Mre11 exonuclease inhibitor (<xref ref-type="bibr" rid="B61">Huh et al., 2016</xref>). This study also suggested that hyperactivation of poly (ADP-ribose) polymerase-1 (Parp-1) during neurogenesis may function as a compensatory mechanism to protect stalled replication forks from collapse and HDR, thus dampening the extent of cell loss during neurogenesis.</p>
<p>During mouse cortical development, the cortical layers are formed in sequential fashion from a pool of neural progenitor cells (NPC) that must continue to proliferate to maintain the pool size. Alterations in NPC proliferation depletes the pool often resulting in altered cell lamination typically observed as a reduction in upper layer neurons. For <italic>Atrx<sup><italic>Foxg</italic>1<italic>Cre</italic></sup></italic> mice, the most proliferative NPCs that ultimately would become upper layer neurons are more susceptible to incur replication-induced DNA damage. Frequently the resulting genomic instability will occur at telomeres and pericentromeric heterochromatin, but it could also occur at other genomic regions that can form G4 DNA or similar secondary DNA structures that induce replication fork stalling and collapse. Accumulation of sufficient damage further leads to their demise and decreases neuron production and brain size. Indeed, the <italic>Atrx<sup><italic>Foxg</italic>1<italic>Cre</italic></sup></italic> forebrain is reduced in size with a compromised production of upper layer neurons (<xref ref-type="bibr" rid="B110">Ritchie et al., 2014</xref>; <xref ref-type="bibr" rid="B61">Huh et al., 2016</xref>). Similar results have been observed in mice lacking CHD4 and SMARCA5 where the NPCs either fail to progress through the cell cycle or incur significant DNA damage, respectively, prior to undergoing apoptosis (<xref ref-type="bibr" rid="B4">Alvarez-Saavedra et al., 2014</xref>, <xref ref-type="bibr" rid="B5">2019</xref>; <xref ref-type="bibr" rid="B94">Nitarska et al., 2016</xref>).</p>
<p>The SWI/SNF complex is also critical for brain development but utilizes different mechanisms than ATRX. The SWI/SNF complex is required during early neurogenesis for differentiation from radial glial progenitor cells into intermediate progenitor cells. This switch from a neural stem cell to an NPC is accompanied by the fundamental shift from the npBAF to nBAF complex, which involves the substitution of three subunits (BAF45, BAF53, and BAF55). Failure to switch leads to increased cell death, a small progenitor pool, and failure to further differentiate (<xref ref-type="bibr" rid="B75">Lessard et al., 2007</xref>; <xref ref-type="bibr" rid="B153">Wu et al., 2007</xref>; <xref ref-type="bibr" rid="B7">Bachmann et al., 2016</xref>). Interestingly, while SMARCA5 loss hampers NPC proliferation, loss of its ISWI ortholog SMARCA1 fails to repress expression of proliferation genes resulting in delayed neuronal differentiation and a larger brain (<xref ref-type="bibr" rid="B157">Yip et al., 2016</xref>). Taken together, these examples highlight the importance of chromatin remodeling proteins to NPC homeostasis and provide insight into the multitude of mechanisms at work often resulting in a similar phenotype.</p>
</sec>
<sec id="S4.SS3">
<title>Transcriptional Deficits Associated With ATRX Mutations</title>
<p>Chromatin remodeling proteins were first identified as transcriptional coactivators and they continue to be implicated in the regulation of many genes. Since its identification, ATRX has also been presumed to regulate gene transcription. While there is a good level of understanding regarding how ATRX maintains genomic stability through the regulation of tandem repeats, telomeres and pericentromeric heterochromatin, the identification of direct transcriptional targets has proven more challenging. Initial ChIPseq experiments suggested that ATRX was bound at few promoters, gene bodies and regulatory elements (<xref ref-type="bibr" rid="B72">Law et al., 2010</xref>). Further work has suggested that ATRX binding may differ between tissues to ensure proper silencing of repetitive elements located near or within expressed genes in that particular tissue (<xref ref-type="bibr" rid="B93">Nguyen et al., 2017</xref>). Consistent with this idea, ATRX ChIPseq analysis of NPCs demonstrated a higher enrichment of binding sites at gene regulatory elements compared to what was observed in mouse ESCs suggesting that more genes may be under direct ATRX regulation within the brain (<xref ref-type="bibr" rid="B72">Law et al., 2010</xref>; <xref ref-type="bibr" rid="B49">He et al., 2015</xref>; <xref ref-type="bibr" rid="B27">Danussi et al., 2018</xref>). Another contributing factor to differential target gene expression is represented by ATRX effects on α-globin gene expression. Mutational analysis identified &gt;15 ATR-X patients with the identical missense change (p.Arg246Cys), yet they showed a variable degree of hemoglobin H inclusions in blood samples, indicative of differing levels of α-globin expression (<xref ref-type="bibr" rid="B40">Gibbons et al., 1997</xref>). Repression of α-globin expression was dependent on the size of a GC-rich VNTR located within the globin gene cluster (<xref ref-type="bibr" rid="B72">Law et al., 2010</xref>). A second factor driving the tissue specificity and the variable effects was the formation of R-loops caused by the transcription of the GC-rich VNTR sequences (<xref ref-type="bibr" rid="B93">Nguyen et al., 2017</xref>). The larger sequences generate increased R-loops and G4 DNA structures that normally recruit ATRX to re-establish the normal chromatin structure. In the absence of ATRX the R-loop/G4 DNA is not resolved effectively which then impedes both replication and transcription processes (<xref ref-type="bibr" rid="B93">Nguyen et al., 2017</xref>). The slight stochastic nature of these effects likely also dampens readouts of differential expression from RNAseq experiments thereby raising the need for a scRNAseq approach in future studies.</p>
<p>Gene expression analysis of control and <italic>Atrx<sup><italic>Foxg</italic>1<italic>Cre</italic></sup></italic> cortical samples at two timepoints (E13.5, P0.5) identified 202 and 304 differentially expressed genes (DEGs; ±1.5-fold change), respectively, with almost two-thirds of genes upregulated (<xref ref-type="bibr" rid="B77">Levy et al., 2008</xref>). Among these, 27 were common to both datasets including the downregulation of several ancestral pseudoautosomal region (aPAR) genes (Csfr2a, Dhrsxy, Cd99, and Asmtl) (<xref ref-type="bibr" rid="B77">Levy et al., 2008</xref>, <xref ref-type="bibr" rid="B78">2014</xref>). In mouse, the aPAR genes are located in subtelomeric regions and contain potential G4 DNA sequences. Each gene analyzed had enriched histone H3.3 and ATRX binding within their gene body and showed reduced H3.3 levels when ATRX was absent (<xref ref-type="bibr" rid="B78">Levy et al., 2014</xref>). Interestingly, these intragene G4 DNA sequences also showed increased binding of RNA pol II in <italic>Atrx<sup><italic>Foxg</italic>1<italic>Cre</italic></sup></italic> samples suggesting that transcription becomes impeded at these regions within the gene leading to reduced expression. The authors extended this finding to <italic>Nlgn4</italic>, a gene encoding a post-synaptic cell adhesion molecule implicated in ASDs (<xref ref-type="bibr" rid="B64">Jamain et al., 2003</xref>; <xref ref-type="bibr" rid="B71">Laumonnier et al., 2004</xref>). This result conflicted with the study on R-loop formation which found no differences in RNA pol II loading or histone modifications across genes containing the GC-rich repeats (<xref ref-type="bibr" rid="B93">Nguyen et al., 2017</xref>).</p>
<p>Other downregulated genes from this analysis include <italic>Gbx2</italic>, <italic>NeuroD4</italic>, <italic>Wif1</italic>, <italic>Nxph1</italic>, <italic>Nxph2</italic>, and <italic>Mbp</italic>, each of which could contribute to cognitive deficits observed in patients but require further analysis to asses their contribution to the phenotype (<xref ref-type="bibr" rid="B77">Levy et al., 2008</xref>, <xref ref-type="bibr" rid="B78">2014</xref>). In a similar experiment in the retina, 173 DEGs were identified with two-thirds upregulated (109 genes) and one-third (64 genes) downregulated (<xref ref-type="bibr" rid="B70">Lagali et al., 2016</xref>). Most of these genes were involved in the regulation of glutamate activity, ion channel regulation or encoded neuroprotective peptides, with four shown to be also dysregulated in the cortex (<italic>Csf2ra</italic>, <italic>Cbln4</italic>, <italic>Syt13</italic>, and <italic>Nlgn4</italic>). Each of these studies showed that the mutant samples had only small numbers of genes with large changes in gene expression and, while some downregulated genes may impede transcriptional elongation, this mechanism may not be universal, particularly as it pertains to upregulated genes.</p>
<p>However, other indirect mechanisms have been explored to explain transcriptional dysregulation, particularly a loss of repression. The ATRX/DAXX complex is critical for loading H3.3 at telomeres and pericentromeric heterochromatin (<xref ref-type="bibr" rid="B43">Goldberg et al., 2010</xref>; <xref ref-type="bibr" rid="B151">Wong et al., 2010</xref>). Research over the last few years has expanded this regulation to include H3.3 deposition at endogenous retroviral elements, regions associated with imprinted genes, and some CpG islands (<xref ref-type="bibr" rid="B34">Elsässer et al., 2015</xref>; <xref ref-type="bibr" rid="B49">He et al., 2015</xref>; <xref ref-type="bibr" rid="B112">Sadic et al., 2015</xref>; <xref ref-type="bibr" rid="B145">Voon et al., 2015</xref>). At the telomere, the loss of ATRX affected the transcription of telomeric DNA and the non-coding RNA TERRA, although studies conflict on whether levels increase or decrease (<xref ref-type="bibr" rid="B33">Eid et al., 2015</xref>; <xref ref-type="bibr" rid="B93">Nguyen et al., 2017</xref>). Surprisingly, TERRA was also shown to bind to an additional ∼4,000 binding sites aside from the telomere where it co-localized with ATRX (<xref ref-type="bibr" rid="B24">Chu et al., 2017</xref>). Many of these sites were within introns and comprised GA repeats, however, depletion of TERRA usually resulted in downregulation while ATRX depletion increased expression (<xref ref-type="bibr" rid="B24">Chu et al., 2017</xref>). While it remains to be determined how this might affect neuronal gene expression, ATRX has been shown to interact with other lncRNAs including <italic>Xist</italic> to facilitate PRC2 silencing and <italic>ChR01</italic> that is required for heterochromatin reorganization in differentiating muscle cells (<xref ref-type="bibr" rid="B116">Sarma et al., 2014</xref>; <xref ref-type="bibr" rid="B99">Park et al., 2018</xref>). Indeed, ATRX binding to lncRNA or R-loops may be a key mechanism mediating transcriptional repression of specific target genes.</p>
<p>Histone H3.3 ChIPseq studies have also shown that it is enriched at the intracisternal A-particle endogenous retroviral elements (IAP/ERVs), which account for almost half of all mutation causing ERV insertions (<xref ref-type="bibr" rid="B87">Maksakova et al., 2006</xref>; <xref ref-type="bibr" rid="B34">Elsässer et al., 2015</xref>). Moreover, H3.3 deposition at these sites requires ATRX/DAXX to facilitate H3K9me3 and repression while depletion of ATRX, DAXX, or H3.3 results in reduction of the H3K9me3 mark and IAP/ERV derepression (<xref ref-type="bibr" rid="B34">Elsässer et al., 2015</xref>; <xref ref-type="bibr" rid="B49">He et al., 2015</xref>; <xref ref-type="bibr" rid="B145">Voon et al., 2015</xref>). In mouse ESCs, ERV derepression affected the expression of neighboring genes in a minority of cases with most genes neutral to ERV derepression. It raises the question of whether or not this type of derepression would affect many genes or occur rapidly within a post-mitotic neuron, and thus, function as a major effector in dysregulated gene expression in <italic>Atrx</italic>-null neurons. In this regard, a related study using cultured post-mitotic neurons demonstrated that the ADD domain can also bind the H3K9me3S10ph dual histone mark (<xref ref-type="bibr" rid="B96">Noh et al., 2015</xref>). This histone mark is rapidly induced by neuronal depolarization where it appears at centromeric and pericentromeric heterochromatin co-localized with ATRX to repress transcription of non-coding centromeric minor satellite sequences (<xref ref-type="bibr" rid="B96">Noh et al., 2015</xref>). While it is unclear what the impact of increased centromeric minor satellite transcription would have on disease pathology, it remains to be determined whether this dual mark affects activity-dependent transcription of genes mediating learning or memory.</p>
<p>It was also demonstrated that ATRX was bound to 56 CpG islands which was unexpected since they are often associated with active chromatin, typically promoters (<xref ref-type="bibr" rid="B145">Voon et al., 2015</xref>). However, these CpG islands were associated with H3K9me3, almost half were methylated and many corresponded to imprinted loci often residing in intragenic regions within a transcriptional unit (<xref ref-type="bibr" rid="B145">Voon et al., 2015</xref>). Indeed, in all cases examined ATRX was bound to the silenced imprinted allele which became reactivated in ATRX KO cells (<xref ref-type="bibr" rid="B145">Voon et al., 2015</xref>). This study contrasted somewhat with an independent report in which ATRX was recruited by MeCP2 to silence the active allele of several imprinted genes in the developing telencephalon (<xref ref-type="bibr" rid="B78">Levy et al., 2014</xref>). The difference in these studies may reflect differential regulation of imprinting loci in ESCs versus differentiating NPCs. Perhaps the most compelling example of derepression came from a study with the <italic>Atrx<sup>Δ<italic>E</italic>2</sup></italic> mice (<xref ref-type="bibr" rid="B123">Shioda et al., 2018</xref>). In this model, the authors identify a small list of 31 DEGs in the adult hippocampus but with most genes (23/31) downregulated (<xref ref-type="bibr" rid="B123">Shioda et al., 2018</xref>). Among the upregulated genes was an imprinted gene from the lymphocyte-regulated gene family, <italic>Xlr3b</italic>. Although <italic>Xlr3b</italic> had widespread expression across many tissues, it was only upregulated in the brain. Further work showed that ATRX bound to a G4 DNA sequence within the CpG island of the <italic>Xlr3b</italic> gene where it normally interacted with DAXX and H3.3 and recruited DNMT1 and DNMT3 to silence the gene. The subsequent overexpression of <italic>Xlr3b</italic> in the <italic>Atrx<sup>Δ<italic>E</italic>2</sup></italic> mice was shown to produce a protein that localized to dendritic RNA granules where it interacted with ribonucleoproteins, dynein proteins and the RNA-binding protein, TIA1, to regulate mRNA transport (<xref ref-type="bibr" rid="B123">Shioda et al., 2018</xref>). One of the targets identified was the mRNA for CAMK II-α which they had previously shown to be deregulated in these animals. Excitingly, they also showed that the G-quadruplex-binding ligand 5-aminolevulinic acid (5-ALA) was able to decrease RNApol II occupancy and <italic>Xlr3b</italic> expression in the <italic>Atrx<sup>Δ<italic>E</italic>2</sup></italic> mice, although methylation of the G4 DNA sequence within the CpG island was not affected. It seems that formation or stabilization of this G4 DNA sequence is required to activate the <italic>Xlr3b</italic> gene and that ATRX normally prevents this by facilitating heterochromatin formation. In this regard, mapping of G4 DNA sequences have shown an enriched number in gene regulatory elements where many function to increase transcription when stabilized (<xref ref-type="bibr" rid="B48">Hänsel-Hertsch et al., 2016</xref>). While G4 DNA stabilization occurs in the <italic>Atrx<sup>Δ<italic>E</italic>2</sup></italic> mice, further work is required to explain how 5-ALA represses Xlr3b transcription when it should stabilize the G4 DNA. Regardless, the derepression of G4 DNA within CpG islands and/or other regulatory elements is an exciting mechanism that can explain DEG upregulation, particularly when coupled with the finding that ATRX binding is increased at regulatory elements in NPCs compared to ESCs. Collectively, the derepression of tandem repeats, retrotransposable elements and G4 quadruplexes can all function to impinge on neuronal function.</p>
</sec>
<sec id="S4.SS4">
<title>Morphological, Behavioral, and Cell Non-autonomous Deficits</title>
<p>We have discussed global effects on DNA replication and transcription that occur in the absence of ATRX in the previous two sections. In this section, we review the morphological and functional repercussions of these deficits. Aside from being reduced in size, the <italic>Atrx<sup><italic>Foxg</italic>1<italic>Cre</italic></sup></italic> mice had a normal cortical morphology with proper lamination although a reduction of upper layer neurons (<xref ref-type="bibr" rid="B14">Bérubé et al., 2005</xref>; <xref ref-type="bibr" rid="B110">Ritchie et al., 2014</xref>; <xref ref-type="bibr" rid="B61">Huh et al., 2016</xref>). The reduction in upper layer neurons may also contribute to the partial agenesis of the corpus callosum observed in some patients (<xref ref-type="bibr" rid="B39">Gibbons, 2006</xref>). The hippocampus was also reduced in size while the dentate gyrus consisted of only a few disorganized cells. Behavior analysis was not performed due to the early postnatal lethality, although female heterozygous mice showed impairment in spatial, contextual fear, and novel object recognition memory (<xref ref-type="bibr" rid="B130">Tamming et al., 2017</xref>).</p>
<p>The <italic>Atrx<sup>Δ<italic>E</italic>2</sup></italic> mice also had smaller brains but no differences in cell density within layers II/III of the prefrontal cortex (PFC) or hippocampus (<xref ref-type="bibr" rid="B122">Shioda et al., 2011</xref>). Examination of dendritic spines in the PFC showed that the <italic>Atrx<sup>Δ<italic>E</italic>2</sup></italic> mice had similar numbers but fewer mature spines and many more, thin, long immature spines (<xref ref-type="bibr" rid="B122">Shioda et al., 2011</xref>). Behavioral analysis indicated that the mice have impaired contextual fear memory (fear conditioning test), spatial memory (Y-maze), but not anxiety behaviors (<xref ref-type="bibr" rid="B95">Nogami et al., 2011</xref>; <xref ref-type="bibr" rid="B122">Shioda et al., 2011</xref>). Electrophysiology studies in hippocampal slices demonstrated reduced NMDAR-dependent long term potentiation (LTP) evoked by high stimulation frequency in hippocampal CA1 neurons which was mediated by increased CAMK2A and GluR1 phosphorylation (<xref ref-type="bibr" rid="B95">Nogami et al., 2011</xref>). This was in contrast to a later article by the same group that showed phosphorylated CAMK2A levels were reduced in the <italic>Atrx<sup>Δ<italic>E</italic>2</sup></italic> mice while 5-ALA restored the levels at the synapse and the phosphorylation levels (<xref ref-type="bibr" rid="B123">Shioda et al., 2018</xref>). A recent article examining hippocampal function using CAMKII-Cre mice to inactivate <italic>Atrx</italic> in postnatal excitatory forebrain neurons demonstrated reduced paired-pulse facilitation and LTP in proximal and distal apical dendrites of CA1 synapses (<xref ref-type="bibr" rid="B46">Gugustea et al., 2019</xref>). This represented the first study of mice in which <italic>Atrx</italic> has been inactivated after neurogenesis and it will be interesting to ascertain the full characterization of these mice.</p>
<p>Studies of the retina have also provided useful information into ATRX function. Many ATR-X patients have visual problems although this has been an under-appreciated aspect of the phenotype (<xref ref-type="bibr" rid="B89">Medina et al., 2009</xref>). Inactivation of ATRX in retinal progenitors <italic>Atrx<sup><italic>Pax</italic>6<italic>Cre</italic></sup></italic> resulted in a slight reduction in retina size and a specific reduction of interneurons, namely amacrine and horizontal cells (<xref ref-type="bibr" rid="B89">Medina et al., 2009</xref>). Surprisingly, <italic>Atrx<sup><italic>Pitf</italic>1<italic>aCre</italic></sup></italic> mice that ablates ATRX in a bi-potential progenitor that generates amacrine or horizontal cells did not recapitulate the phenotype, while inactivation with a bipolar cell specific Cre driver (<italic>Atrx<sup><italic>Vsx</italic>2<italic>Cre</italic></sup></italic>) did not affect bipolar cell survival but did result in reduced amacrine and horizontal cells suggesting that interneuron survival was a cell non-autonomous effect (<xref ref-type="bibr" rid="B70">Lagali et al., 2016</xref>). Additional characterization of these mice showed that the bipolar axons were mislocalized within the inner plexiform layer and many had axonal swellings or tortuous paths to their targets. Gene expression analysis identified alterations in the glutamate pathway, ion channel regulation and altered expression of neuroprotective peptides. Altered axonal pathfinding was also observed in Drosophila XNP mutants, the homolog to the ATPase domain of ATRX (<xref ref-type="bibr" rid="B129">Sun et al., 2006</xref>). It will be important to further explore in greater detail whether axonal pathfinding is also altered within forebrain or hippocampal neurons.</p>
</sec>
</sec>
<sec id="S5">
<title>Perspectives</title>
<p>Studies to date have indicated that ATRX has multiple roles during forebrain development that can contribute to the phenotype of ATR-X patients. It functions mainly as a heterochromatin interacting protein acting to ensure that repetitive DNA is properly packaged and organized into heterochromatin. We have highlighted how aberrations in heterochromatin maintenance leads to genomic instability and replication stress that impairs NPC expansion leading to a microcephalic brain (<xref ref-type="fig" rid="F3">Figure 3</xref>). The loss of ATRX also affects gene expression typically resulting in increased gene derepression but also downregulation. It remains to be teased apart which targets are direct versus indirect, and when disrupted expression hampers neuronal function. It is likely that inactivation of ATRX in postmitotic neurons, following neurogenesis and lamination, will help define a role for ATRX target genes in altered synaptic activity and/or synaptic plasticity underlying cognitive impairment. Moreover, the contribution of other central nervous system cell types to the phenotype have not been explored. ATRX is expressed in glia and oligodendrocytes which are known to intimately communicate with neurons to mediate function, as shown recently in <italic>Drosophila</italic> glial ATRX dependent ensheathment of sensory neurons, for normal dendritic arborization and stimulus processing (<xref ref-type="bibr" rid="B156">Yadav et al., 2019</xref>). Intriguingly, MRI studies on ATR-X patients showed severe glial defects and white matter disruption, further stressing the need for research in this area (<xref ref-type="bibr" rid="B146">Wada et al., 2013</xref>; <xref ref-type="bibr" rid="B74">Lee et al., 2015</xref>). Importantly, a further understanding of ATRX function and its aberrant molecular pathways are required before potential treatments can be explored. In this regard, treatment with 5-ALA has shown promise in one animal model and it is being investigated in Japanese patients (T. Wada, personal communication). ATRX is but one of many different chromatin remodeling proteins mutated in NDDs but it serves to demonstrate how complex these disorders are and how widely chromatin remodelers impact cellular activities.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>The multiple functions of the ATRX protein. Schematic diagram of ATRX functional influence on brain development and its contribution to NDDs. Normally ATRX utilizes its chromatin remodeling activity to (1) influence transcription and DNA replication in heterochromatic regions to control the rate of proliferation in the neuronal progenitor cell population (bottom arm); and (2) to influence transcription in heterochromatic regions to control differentiation processes (top arm). When ATRX is mutated the cellular proliferation rates in progenitors is slowed resulting in a smaller progenitor population; and the differentiation processes are altered resulting in either dysfunctional cellular morphology or complete absence of specific cell types.</p>
</caption>
<graphic xlink:href="fgene-11-00885-g003"></graphic>
</fig>
</sec>
<sec id="S6">
<title>Author Contributions</title>
<p>ST and DP wrote and edited the manuscript together. ST generated the figures and table. Both authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="conf1">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> The research supporting this work was funded by two operating grants (FRN133586 and FRN165994) from the Canadian Institute of Health Research awarded to DP.</p>
</fn>
</fn-group>
<ack>
<p>We are grateful to Dr. Alex Córdova and Valérie Cardin for their valued input and critical reading of the manuscript.</p>
</ack>
<fn-group>
<fn id="footnote1">
<label>1</label>
<p>
<ext-link ext-link-type="uri" xlink:href="https://sysid.cmbi.umcn.nl/">https://sysid.cmbi.umcn.nl/</ext-link>
</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abidi</surname><given-names>F. E.</given-names></name><name><surname>Cardoso</surname><given-names>C.</given-names></name><name><surname>Lossi</surname><given-names>A. M.</given-names></name><name><surname>Lowry</surname><given-names>R. B.</given-names></name><name><surname>Depetris</surname><given-names>D.</given-names></name><name><surname>Mattéi</surname><given-names>M. G.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Mutation in the 5′ alternatively spliced region of the XNP/ATR-X gene causes Chudley-Lowry syndrome.</article-title>
<source/><italic>Eur. J. Hum. Genet.</italic>
<volume>13</volume>
<fpage>176</fpage>–<lpage>183</lpage>. <pub-id pub-id-type="doi">10.1038/sj.ejhg.5201303</pub-id>
<pub-id pub-id-type="pmid">15508018</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alazami</surname><given-names>A. M.</given-names></name><name><surname>Patel</surname><given-names>N.</given-names></name><name><surname>Shamseldin</surname><given-names>H. E.</given-names></name><name><surname>Anazi</surname><given-names>S.</given-names></name><name><surname>Al-Dosari</surname><given-names>M. S.</given-names></name><name><surname>Alzahrani</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Accelerating novel candidate gene discovery in neurogenetic disorders via whole-exome sequencing of prescreened multiplex consanguineous families.</article-title>
<source/><italic>Cell Rep.</italic>
<volume>10</volume>
<fpage>148</fpage>–<lpage>161</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2014.12.015</pub-id>
<pub-id pub-id-type="pmid">25558065</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alfert</surname><given-names>A.</given-names></name><name><surname>Moreno</surname><given-names>N.</given-names></name><name><surname>Kerl</surname><given-names>K.</given-names></name></person-group> (<year>2019</year>). <article-title>The BAF complex in development and disease.</article-title>
<source/><italic>Epigenet. Chromat.</italic>
<volume>12</volume>
<fpage>1</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1186/s13072-019-0264-y</pub-id>
<pub-id pub-id-type="pmid">30898143</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvarez-Saavedra</surname><given-names>M.</given-names></name><name><surname>De Repentigny</surname><given-names>Y.</given-names></name><name><surname>Lagali</surname><given-names>P. S.</given-names></name><name><surname>Raghu Ram</surname><given-names>E. V. S.</given-names></name><name><surname>Yan</surname><given-names>K.</given-names></name><name><surname>Hashem</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Snf2h-mediated chromatin organization and histone H1 dynamics govern cerebellar morphogenesis and neural maturation.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>5</volume>:<issue>5181</issue>. <pub-id pub-id-type="doi">10.1038/ncomms5181</pub-id>
<pub-id pub-id-type="pmid">24946904</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvarez-Saavedra</surname><given-names>M.</given-names></name><name><surname>Yan</surname><given-names>K.</given-names></name><name><surname>De Repentigny</surname><given-names>Y.</given-names></name><name><surname>Hashem</surname><given-names>L. E.</given-names></name><name><surname>Chaudary</surname><given-names>N.</given-names></name><name><surname>Sarwar</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Snf2h drives chromatin remodeling to prime upper layer cortical neuron development.</article-title>
<source/><italic>Front. Mol. Neurosci.</italic>
<volume>12</volume>:<issue>243</issue>. <pub-id pub-id-type="doi">10.3389/fnmol.2019.00243</pub-id>
<pub-id pub-id-type="pmid">31680852</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Argentaro</surname><given-names>A.</given-names></name><name><surname>Yang</surname><given-names>J. C.</given-names></name><name><surname>Chapman</surname><given-names>L.</given-names></name><name><surname>Kowalczyk</surname><given-names>M. S.</given-names></name><name><surname>Gibbons</surname><given-names>R. J.</given-names></name><name><surname>Higgs</surname><given-names>D. R.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Structural consequences of disease-causing mutations in the ATRX-DNMT3-DNMT3L (ADD) domain of the chromatin-associated protein ATRX.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>104</volume>
<fpage>11939</fpage>–<lpage>11944</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0704057104</pub-id>
<pub-id pub-id-type="pmid">17609377</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bachmann</surname><given-names>C.</given-names></name><name><surname>Nguyen</surname><given-names>H.</given-names></name><name><surname>Rosenbusch</surname><given-names>J.</given-names></name><name><surname>Pham</surname><given-names>L.</given-names></name><name><surname>Rabe</surname><given-names>T.</given-names></name><name><surname>Patwa</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>mSWI/SNF (BAF) complexes are indispensable for the neurogenesis and development of embryonic olfactory epithelium.</article-title>
<source/><italic>PLoS Genet.</italic>
<volume>12</volume>:<issue>6274</issue>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1006274</pub-id>
<pub-id pub-id-type="pmid">27611684</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Badens</surname><given-names>C.</given-names></name><name><surname>Lacoste</surname><given-names>C.</given-names></name><name><surname>Philip</surname><given-names>N.</given-names></name><name><surname>Martini</surname><given-names>N.</given-names></name><name><surname>Courrier</surname><given-names>S.</given-names></name><name><surname>Giuliano</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Mutations in PHD-like domain of the ATRX gene correlate with severe psychomotor impairment and severe urogenital abnormalities in patients with ATRX syndrome.</article-title>
<source/><italic>Clin. Genet.</italic>
<volume>70</volume>
<fpage>57</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1111/j.1399-0004.2006.00641.x</pub-id>
<pub-id pub-id-type="pmid">16813605</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bagheri-fam</surname><given-names>S.</given-names></name><name><surname>Argentaro</surname><given-names>A.</given-names></name><name><surname>Svingen</surname><given-names>T.</given-names></name><name><surname>Combes</surname><given-names>A. N.</given-names></name><name><surname>Sinclair</surname><given-names>A. H.</given-names></name><name><surname>Koopman</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Defective survival of proliferating sertoli cells and androgen receptor function in a mouse model of the ATR-X syndrome.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>20</volume>
<fpage>2213</fpage>–<lpage>2224</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddr109</pub-id>
<pub-id pub-id-type="pmid">21427128</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bannister</surname><given-names>A. J.</given-names></name><name><surname>Zegerman</surname><given-names>P.</given-names></name><name><surname>Partridge</surname><given-names>J. F.</given-names></name><name><surname>Miska</surname><given-names>E. A.</given-names></name><name><surname>Thomas</surname><given-names>J. O.</given-names></name><name><surname>Allshire</surname><given-names>R. C.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain.</article-title>
<source/><italic>Nature</italic>
<volume>410</volume>
<fpage>120</fpage>–<lpage>124</lpage>. <pub-id pub-id-type="doi">10.1038/35065138</pub-id>
<pub-id pub-id-type="pmid">11242054</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basehore</surname><given-names>M. J.</given-names></name><name><surname>Michaelson-Cohen</surname><given-names>R.</given-names></name><name><surname>Levy-Lahad</surname><given-names>E.</given-names></name><name><surname>Sismani</surname><given-names>C.</given-names></name><name><surname>Bird</surname><given-names>L. M.</given-names></name><name><surname>Friez</surname><given-names>M. J.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Alpha-thalassemia intellectual disability: variable phenotypic expression among males with a recurrent nonsense mutation - c.<italic>109C</italic>&gt;T (p.R37X).</article-title>
<source/><italic>Clin. Genet.</italic>
<volume>87</volume>
<fpage>461</fpage>–<lpage>466</lpage>. <pub-id pub-id-type="doi">10.1111/cge.12420</pub-id>
<pub-id pub-id-type="pmid">24805811</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bérubé</surname><given-names>N. G.</given-names></name><name><surname>Healy</surname><given-names>J.</given-names></name><name><surname>Medina</surname><given-names>C. F.</given-names></name><name><surname>Wu</surname><given-names>S.</given-names></name><name><surname>Hodgson</surname><given-names>T.</given-names></name><name><surname>Jagla</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Patient mutations alter ATRX targeting to PML nuclear bodies.</article-title>
<source/><italic>Eur. J. Hum. Genet.</italic>
<volume>16</volume>
<fpage>192</fpage>–<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1038/sj.ejhg.5201943</pub-id>
<pub-id pub-id-type="pmid">17957225</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berube</surname><given-names>N. G.</given-names></name><name><surname>Jagla</surname><given-names>M.</given-names></name><name><surname>Smeenk</surname><given-names>C.</given-names></name><name><surname>De Repentigny</surname><given-names>Y.</given-names></name><name><surname>Kothary</surname><given-names>R.</given-names></name><name><surname>Picketts</surname><given-names>D. J.</given-names></name></person-group> (<year>2002</year>). <article-title>Neurodevelopmental defects resulting from ATRX overexpression in transgenic mice.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>11</volume>
<fpage>253</fpage>–<lpage>261</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/11.3.253</pub-id>
<pub-id pub-id-type="pmid">11823444</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bérubé</surname><given-names>N. G.</given-names></name><name><surname>Mangelsdorf</surname><given-names>M.</given-names></name><name><surname>Jagla</surname><given-names>M.</given-names></name><name><surname>Vanderluit</surname><given-names>J.</given-names></name><name><surname>Garrick</surname><given-names>D.</given-names></name><name><surname>Gibbons</surname><given-names>R. J.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>The chromatin-remodeling protein ATRX is critical for neuronal survival during corticogenesis.</article-title>
<source/><italic>J. Clin. Invest.</italic>
<volume>115</volume>
<fpage>258</fpage>–<lpage>267</lpage>. <pub-id pub-id-type="doi">10.1172/JCI200522329</pub-id><pub-id pub-id-type="pmid">15668733</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berube</surname><given-names>N. G.</given-names></name><name><surname>Smeenk</surname><given-names>C. A.</given-names></name><name><surname>Picketts</surname><given-names>D. J.</given-names></name></person-group> (<year>2000</year>). <article-title>Cell cycle-dependent phosphorylation of the ATRX protein correlates with changes in nuclear matrix and chromatin association.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>9</volume>
<fpage>539</fpage>–<lpage>547</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/9.4.539</pub-id>
<pub-id pub-id-type="pmid">10699177</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bettin</surname><given-names>N.</given-names></name><name><surname>Oss Pegorar</surname><given-names>C.</given-names></name><name><surname>Cusanelli</surname><given-names>E.</given-names></name></person-group> (<year>2019</year>). <article-title>The emerging roles of TERRA in telomere maintenance and genome stability.</article-title>
<source/><italic>Cells</italic>
<volume>8</volume>:<issue>246</issue>. <pub-id pub-id-type="doi">10.3390/cells8030246</pub-id>
<pub-id pub-id-type="pmid">30875900</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bögershausen</surname><given-names>N.</given-names></name><name><surname>Wollnik</surname><given-names>B.</given-names></name></person-group> (<year>2018</year>). <article-title>Mutational Landscapes and Phenotypic Spectrum of SWI/SNF-related intellectual disability disorders.</article-title>
<source/><italic>Front. Mol. Neurosci.</italic>
<volume>11</volume>:<issue>252</issue>. <pub-id pub-id-type="doi">10.3389/fnmol.2018.00252</pub-id>
<pub-id pub-id-type="pmid">30123105</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowman</surname><given-names>G. D.</given-names></name><name><surname>Poirier</surname><given-names>M. G.</given-names></name></person-group> (<year>2015</year>). <article-title>Post-translational modifications of histones that influence nucleosome dynamics.</article-title>
<source/><italic>Chem. Rev.</italic>
<volume>115</volume>
<fpage>2274</fpage>–<lpage>2295</lpage>. <pub-id pub-id-type="doi">10.1021/cr500350x</pub-id>
<pub-id pub-id-type="pmid">25424540</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bramswig</surname><given-names>N. C.</given-names></name><name><surname>Caluseriu</surname><given-names>O.</given-names></name><name><surname>Lüdecke</surname><given-names>H. J.</given-names></name><name><surname>Bolduc</surname><given-names>F. V.</given-names></name><name><surname>Noel</surname><given-names>N. C. L.</given-names></name><name><surname>Wieland</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Heterozygosity for ARID2 loss-of-function mutations in individuals with a Coffin-Siris syndrome-like phenotype.</article-title>
<source/><italic>Hum. Genet.</italic>
<volume>136</volume>
<fpage>297</fpage>–<lpage>305</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-017-1757-z</pub-id>
<pub-id pub-id-type="pmid">28124119</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardoso</surname><given-names>C.</given-names></name><name><surname>Lutz</surname><given-names>Y.</given-names></name><name><surname>Mignon</surname><given-names>C.</given-names></name><name><surname>Compe</surname><given-names>E.</given-names></name><name><surname>Depetris</surname><given-names>D.</given-names></name><name><surname>Mattei</surname><given-names>M. G.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>ATR-X mutations cause impaired nuclear location and altered DNA binding properties of the XNP/ATR-X protein.</article-title>
<source/><italic>J. Med. Genet.</italic>
<volume>37</volume>
<fpage>746</fpage>–<lpage>751</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.37.10.746</pub-id>
<pub-id pub-id-type="pmid">11015451</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardoso</surname><given-names>C.</given-names></name><name><surname>Timsit</surname><given-names>S.</given-names></name><name><surname>Villard</surname><given-names>L.</given-names></name><name><surname>Khrestchatisky</surname><given-names>M.</given-names></name><name><surname>Fontès</surname><given-names>M.</given-names></name><name><surname>Colleaux</surname><given-names>L.</given-names></name></person-group> (<year>1998</year>). <article-title>Specific interaction between the XNP/ATR-X gene product and the SET domain of the human EZH2 protein.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>7</volume>
<fpage>679</fpage>–<lpage>684</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/7.4.679</pub-id>
<pub-id pub-id-type="pmid">9499421</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carpenter</surname><given-names>N. J.</given-names></name><name><surname>Qu</surname><given-names>Y.</given-names></name><name><surname>Curtis</surname><given-names>M.</given-names></name><name><surname>Patil</surname><given-names>S. R.</given-names></name></person-group> (<year>1999</year>). <article-title>X-linked mental retardation syndrome with characteristic “coarse” facial appearance, brachydactyly, and short stature maps to proximal Xq.</article-title>
<source/><italic>Am. J. Med. Genet.</italic>
<volume>85</volume>
<fpage>230</fpage>–<lpage>235</lpage>. <pub-id pub-id-type="doi">10.1002/(sici)1096-8628(19990730)85:3&lt;230::aid-ajmg9&gt;3.0.co;2-o</pub-id><pub-id pub-id-type="pmid">10398234</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carvill</surname><given-names>G. L.</given-names></name><name><surname>Heavin</surname><given-names>S. B.</given-names></name><name><surname>Yendle</surname><given-names>S. C.</given-names></name><name><surname>McMahon</surname><given-names>J. M.</given-names></name><name><surname>O’Roak</surname><given-names>B. J.</given-names></name><name><surname>Cook</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>45</volume>
<fpage>825</fpage>–<lpage>830</lpage>. <pub-id pub-id-type="doi">10.1002/jmri.25711.PET/MRI</pub-id><pub-id pub-id-type="pmid">23708187</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>H.</given-names></name><name><surname>Cifuentes-rojas</surname><given-names>C.</given-names></name><name><surname>Kesner</surname><given-names>B.</given-names></name><name><surname>Aeby</surname><given-names>E.</given-names></name><name><surname>Lee</surname><given-names>H.</given-names></name><name><surname>Wei</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>TERRA RNA antagonizes ATRX and protects telomeres.</article-title>
<source/><italic>Cell</italic>
<volume>170</volume>
<fpage>86</fpage>–<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2017.06.017.TERRA</pub-id><pub-id pub-id-type="pmid">28666128</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clapier</surname><given-names>C. R.</given-names></name><name><surname>Iwasa</surname><given-names>J.</given-names></name><name><surname>Cairns</surname><given-names>B. R.</given-names></name><name><surname>Peterson</surname><given-names>C. L.</given-names></name></person-group> (<year>2017</year>). <article-title>Mechanisms of action and regulation of ATP-dependent chromatin-remodelling complexes.</article-title>
<source/><italic>Nat. Rev. Mol. Cell Biol.</italic>
<volume>18</volume>
<fpage>407</fpage>–<lpage>422</lpage>. <pub-id pub-id-type="doi">10.1038/nrm.2017.26</pub-id>
<pub-id pub-id-type="pmid">28512350</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clynes</surname><given-names>D.</given-names></name><name><surname>Jelinska</surname><given-names>C.</given-names></name><name><surname>Xella</surname><given-names>B.</given-names></name><name><surname>Ayyub</surname><given-names>H.</given-names></name><name><surname>Taylor</surname><given-names>S.</given-names></name><name><surname>Mitson</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>ATRX dysfunction induces replication defects in primary mouse cells.</article-title>
<source/><italic>PLoS One</italic>
<volume>9</volume>:<issue>e092915</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0092915</pub-id>
<pub-id pub-id-type="pmid">24651726</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danussi</surname><given-names>C.</given-names></name><name><surname>Bose</surname><given-names>P.</given-names></name><name><surname>Parthasarathy</surname><given-names>P. T.</given-names></name><name><surname>Silberman</surname><given-names>P. C.</given-names></name><name><surname>Van Arnam</surname><given-names>J. S.</given-names></name><name><surname>Vitucci</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodeling.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>9</volume>
<fpage>1</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1038/s41467-018-03476-3476</pub-id><pub-id pub-id-type="pmid">29317637</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Rubeis</surname><given-names>S.</given-names></name><name><surname>He</surname><given-names>X.</given-names></name><name><surname>Goldberg</surname><given-names>A.</given-names></name><name><surname>Poultney</surname><given-names>C.</given-names></name><name><surname>Samocha</surname><given-names>K.</given-names></name><name><surname>Cicek</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Synaptic, transcriptional, and chromatin genes disrupted in autism.</article-title>
<source/><italic>Nature</italic>
<volume>515</volume>
<fpage>209</fpage>–<lpage>215</lpage>.<pub-id pub-id-type="pmid">25363760</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delbarre</surname><given-names>E.</given-names></name><name><surname>Ivanauskienne</surname><given-names>K.</given-names></name><name><surname>Spirkoski</surname><given-names>J.</given-names></name><name><surname>Shah</surname><given-names>A.</given-names></name><name><surname>Vekterud</surname><given-names>K.</given-names></name><name><surname>Oivind Moskaug</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>PML protein organizes heterochromatin domains where it regulates histone H3. 3 loading by ATRX / DAXX.</article-title>
<source/><italic>Genome Res.</italic>
<volume>27</volume>
<fpage>913</fpage>–<lpage>921</lpage>. <pub-id pub-id-type="doi">10.1101/gr.215830.116.6</pub-id><pub-id pub-id-type="pmid">28341773</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhayalan</surname><given-names>A.</given-names></name><name><surname>Tamas</surname><given-names>R.</given-names></name><name><surname>Bock</surname><given-names>I.</given-names></name><name><surname>Tattermusch</surname><given-names>A.</given-names></name><name><surname>Dimitrova</surname><given-names>E.</given-names></name><name><surname>Kudithipudi</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>The ATRX-ADD domain binds to H3 tail peptides and reads the combined methylation state of K4 and K9.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>20</volume>
<fpage>2195</fpage>–<lpage>2203</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddr107</pub-id>
<pub-id pub-id-type="pmid">21421568</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drané</surname><given-names>P.</given-names></name><name><surname>Ouararhni</surname><given-names>K.</given-names></name><name><surname>Depaux</surname><given-names>A.</given-names></name><name><surname>Shuaib</surname><given-names>M.</given-names></name><name><surname>Hamiche</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3.</article-title>
<source/><italic>Genes Dev.</italic>
<volume>24</volume>
<fpage>1253</fpage>–<lpage>1265</lpage>. <pub-id pub-id-type="doi">10.1101/gad.566910</pub-id>
<pub-id pub-id-type="pmid">20504901</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dyer</surname><given-names>M. A.</given-names></name><name><surname>Qadeer</surname><given-names>Z. A.</given-names></name><name><surname>Valle-Garcia</surname><given-names>D.</given-names></name><name><surname>Bernstein</surname><given-names>E.</given-names></name></person-group> (<year>2017</year>). <article-title>ATRX and DAXX: mechanisms and mutations.</article-title>
<source/><italic>Cold Spring Harb. Perspect. Med.</italic>
<volume>7</volume>
<fpage>1</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1101/cshperspect.a026567</pub-id>
<pub-id pub-id-type="pmid">28062559</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eid</surname><given-names>R.</given-names></name><name><surname>Demattei</surname><given-names>M.-V.</given-names></name><name><surname>Episkopou</surname><given-names>H.</given-names></name><name><surname>Augé-Gouillou</surname><given-names>C.</given-names></name><name><surname>Decottignies</surname><given-names>A.</given-names></name><name><surname>Grandin</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Genetic inactivation of ATRX leads to a decrease in the amount of telomeric cohesin and level of telomere transcription in human glioma cells.</article-title>
<source/><italic>Mol. Cell. Biol.</italic>
<volume>35</volume>
<fpage>2818</fpage>–<lpage>2830</lpage>. <pub-id pub-id-type="doi">10.1128/mcb.01317-1314</pub-id><pub-id pub-id-type="pmid">26055325</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elsässer</surname><given-names>S. J.</given-names></name><name><surname>Noh</surname><given-names>K.-M.</given-names></name><name><surname>Diaz</surname><given-names>N.</given-names></name><name><surname>Allis</surname><given-names>D.</given-names></name><name><surname>Banaszynski</surname><given-names>L. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Histone H3.3 is required for endogenous retroviral element silencing in embryonic stem cells.</article-title>
<source/><italic>Nature</italic>
<volume>522</volume>
<fpage>240</fpage>–<lpage>244</lpage>. <pub-id pub-id-type="doi">10.1038/nature14345</pub-id>
<pub-id pub-id-type="pmid">25938714</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eustermann</surname><given-names>S.</given-names></name><name><surname>Yang</surname><given-names>J. C.</given-names></name><name><surname>Law</surname><given-names>M. J.</given-names></name><name><surname>Amos</surname><given-names>R.</given-names></name><name><surname>Chapman</surname><given-names>L. M.</given-names></name><name><surname>Jelinska</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Combinatorial readout of histone H3 modifications specifies localization of ATRX to heterochromatin.</article-title>
<source/><italic>Nat. Struct. Mol. Biol.</italic>
<volume>18</volume>
<fpage>777</fpage>–<lpage>782</lpage>. <pub-id pub-id-type="doi">10.1038/nsmb.2070</pub-id>
<pub-id pub-id-type="pmid">21666677</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garrick</surname><given-names>D.</given-names></name><name><surname>Samara</surname><given-names>V.</given-names></name><name><surname>McDowell</surname><given-names>T. L.</given-names></name><name><surname>Smith</surname><given-names>A. J. H.</given-names></name><name><surname>Dobbie</surname><given-names>L.</given-names></name><name><surname>Higgs</surname><given-names>D. R.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>A conserved truncated isoform of the ATR-X syndrome protein lacking the SWI/SNF-homology domain.</article-title>
<source/><italic>Gene</italic>
<volume>326</volume>
<fpage>23</fpage>–<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/j.gene.2003.10.026</pub-id>
<pub-id pub-id-type="pmid">14729260</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garrick</surname><given-names>D.</given-names></name><name><surname>Sharpe</surname><given-names>J. A.</given-names></name><name><surname>Arkell</surname><given-names>R.</given-names></name><name><surname>Dobbie</surname><given-names>L.</given-names></name><name><surname>Smith</surname><given-names>A. J. H.</given-names></name><name><surname>Wood</surname><given-names>W. G.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Loss of Atrx affects trophoblast development and the pattern of X-inactivation in extraembryonic tissues.</article-title>
<source/><italic>PLoS Genet.</italic>
<volume>2</volume>:<issue>e58</issue>. <pub-id pub-id-type="doi">10.1371/journal.pgen.0020058</pub-id>
<pub-id pub-id-type="pmid">16628246</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gemmen</surname><given-names>G. J.</given-names></name><name><surname>Sim</surname><given-names>R.</given-names></name><name><surname>Haushalter</surname><given-names>K. A.</given-names></name><name><surname>Ke</surname><given-names>P. C.</given-names></name><name><surname>Kadonaga</surname><given-names>J. T.</given-names></name><name><surname>Smith</surname><given-names>D. E.</given-names></name></person-group> (<year>2005</year>). <article-title>Forced unraveling of nucleosomes assembled on heterogeneous DNA using core histones, NAP-1, and ACF.</article-title>
<source/><italic>J. Mol. Biol.</italic>
<volume>351</volume>
<fpage>89</fpage>–<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2005.05.058</pub-id>
<pub-id pub-id-type="pmid">16002089</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibbons</surname><given-names>R.</given-names></name></person-group> (<year>2006</year>). <article-title>Alpha thalassaemia-mental retardation, X linked.</article-title>
<source/><italic>Orphanet J. Rare Dis.</italic>
<volume>1</volume>
<fpage>1</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1186/1750-1172-1-15</pub-id>
<pub-id pub-id-type="pmid">16722615</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibbons</surname><given-names>R. J.</given-names></name><name><surname>Bachoo</surname><given-names>S.</given-names></name><name><surname>Picketts</surname><given-names>D. J.</given-names></name><name><surname>Aftimos</surname><given-names>S.</given-names></name><name><surname>Asenbauer</surname><given-names>B.</given-names></name><name><surname>Bergoffen</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>1997</year>). <article-title>Mutations in transcriptional regulator ATRX establish the functional significance of a PHD-like domain.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>17</volume>
<fpage>146</fpage>–<lpage>148</lpage>. <pub-id pub-id-type="doi">10.1038/ng1097-146</pub-id>
<pub-id pub-id-type="pmid">9326931</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibbons</surname><given-names>R. J.</given-names></name><name><surname>Picketts</surname><given-names>D. J.</given-names></name><name><surname>Villard</surname><given-names>L.</given-names></name><name><surname>Higgs</surname><given-names>D. R.</given-names></name></person-group> (<year>1995</year>). <article-title>Mutations in a putative global transcriptional regulator cause X-linked mental retardation with α-thalassemia (ATR-X syndrome).</article-title>
<source/><italic>Cell</italic>
<volume>80</volume>
<fpage>837</fpage>–<lpage>845</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(95)90287-90282</pub-id><pub-id pub-id-type="pmid">7697714</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibbons</surname><given-names>R. J.</given-names></name><name><surname>Wada</surname><given-names>T.</given-names></name><name><surname>Fisher</surname><given-names>C. A.</given-names></name><name><surname>Malik</surname><given-names>N.</given-names></name><name><surname>Mitson</surname><given-names>M. J.</given-names></name><name><surname>Steensma</surname><given-names>D. P.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Mutations in the chromatin-associated protein ATRX.</article-title>
<source/><italic>Hum. Mutat.</italic>
<volume>29</volume>
<fpage>796</fpage>–<lpage>802</lpage>. <pub-id pub-id-type="doi">10.1002/humu.20734</pub-id>
<pub-id pub-id-type="pmid">18409179</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldberg</surname><given-names>A. D.</given-names></name><name><surname>Banaszynski</surname><given-names>L. A.</given-names></name><name><surname>Noh</surname><given-names>K.</given-names></name><name><surname>Lewis</surname><given-names>P. W.</given-names></name><name><surname>Elsaesser</surname><given-names>S. J.</given-names></name><name><surname>Stadler</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Distinct factors control histone variant H3.3 localization at specific genomic regions.</article-title>
<source/><italic>Science</italic>
<volume>140</volume>
<fpage>678</fpage>–<lpage>691</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2010.01.003.Distinct</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodwin</surname><given-names>L. R.</given-names></name><name><surname>Picketts</surname><given-names>D. J.</given-names></name></person-group> (<year>2018</year>). <article-title>The role of ISWI chromatin remodeling complexes in brain development and neurodevelopmental disorders.</article-title>
<source/><italic>Mol. Cell. Neurosci.</italic>
<volume>87</volume>
<fpage>55</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2017.10.008</pub-id>
<pub-id pub-id-type="pmid">29249292</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guerrini</surname><given-names>R.</given-names></name><name><surname>Shanahan</surname><given-names>J. L.</given-names></name><name><surname>Carrozzo</surname><given-names>R.</given-names></name><name><surname>Bonanni</surname><given-names>P.</given-names></name><name><surname>Higgs</surname><given-names>D. R.</given-names></name><name><surname>Gibbons</surname><given-names>R. J.</given-names></name></person-group> (<year>2000</year>). <article-title>Hemizygous mutation of the peripheral myelin protein 22 gene associated with Charcot-Marie-Tooth disease type 1.</article-title>
<source/><italic>Ann. Neurol.</italic>
<volume>47</volume>
<fpage>117</fpage>–<lpage>121</lpage>.<pub-id pub-id-type="pmid">10632111</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gugustea</surname><given-names>R.</given-names></name><name><surname>Tamming</surname><given-names>R. J.</given-names></name><name><surname>Martin-Kenny</surname><given-names>N.</given-names></name><name><surname>Bérubé</surname><given-names>N. G.</given-names></name><name><surname>Leung</surname><given-names>L. S.</given-names></name></person-group> (<year>2019</year>). <article-title>Inactivation of ATRX in forebrain excitatory neurons affects hippocampal synaptic plasticity.</article-title>
<source/><italic>Hippocampus</italic>
<volume>30</volume>
<fpage>565</fpage>–<lpage>581</lpage>. <pub-id pub-id-type="doi">10.1002/hipo.23174</pub-id>
<pub-id pub-id-type="pmid">31713968</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>D. C.</given-names></name><name><surname>Duan</surname><given-names>X. Y.</given-names></name><name><surname>Regalado</surname><given-names>E. S.</given-names></name><name><surname>Mellor-Crummey</surname><given-names>L.</given-names></name><name><surname>Kwartler</surname><given-names>C. S.</given-names></name><name><surname>Kim</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Loss-of-function mutations in YY1AP1 lead to grange syndrome and a fibromuscular dysplasia-like vascular disease.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>100</volume>
<fpage>21</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2016.11.008</pub-id>
<pub-id pub-id-type="pmid">27939641</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hänsel-Hertsch</surname><given-names>R.</given-names></name><name><surname>Beraldi</surname><given-names>D.</given-names></name><name><surname>Lensing</surname><given-names>S. V.</given-names></name><name><surname>Marsico</surname><given-names>G.</given-names></name><name><surname>Zyner</surname><given-names>K.</given-names></name><name><surname>Parry</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>G-quadruplex structures mark human regulatory chromatin.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>48</volume>
<fpage>1267</fpage>–<lpage>1272</lpage>. <pub-id pub-id-type="doi">10.1038/ng.3662</pub-id>
<pub-id pub-id-type="pmid">27618450</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>Q.</given-names></name><name><surname>Kim</surname><given-names>H.</given-names></name><name><surname>Huang</surname><given-names>R.</given-names></name><name><surname>Lu</surname><given-names>W.</given-names></name><name><surname>Tang</surname><given-names>M.</given-names></name><name><surname>Shi</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>The Daxx/Atrx complex protects tandem repetitive elements during DNA hypomethylation by promoting H3K9 trimethylation.</article-title>
<source/><italic>Cell Stem Cell</italic>
<volume>17</volume>
<fpage>273</fpage>–<lpage>286</lpage>. <pub-id pub-id-type="doi">10.1016/j.stem.2015.07.022</pub-id>
<pub-id pub-id-type="pmid">26340527</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heaphy</surname><given-names>C. M.</given-names></name><name><surname>Wilde</surname><given-names>R. F.</given-names></name><name><surname>De Jiao</surname><given-names>Y.</given-names></name><name><surname>Klein</surname><given-names>A. P.</given-names></name><name><surname>Edil</surname><given-names>B. H.</given-names></name><name><surname>Shi</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Altered telormeres in tumors with ATRX and DAXX mutations.</article-title>
<source/><italic>Science</italic>
<volume>333</volume>
<fpage>1</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1126/science.1207313.Altered</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hébert</surname><given-names>J. M.</given-names></name><name><surname>McConnell</surname><given-names>S. K.</given-names></name></person-group> (<year>2000</year>). <article-title>Targeting of cre to the Foxg1 (BF-1) locus mediates loxP recombination in the telencephalon and other developing head structures.</article-title>
<source/><italic>Dev. Biol.</italic>
<volume>222</volume>
<fpage>296</fpage>–<lpage>306</lpage>. <pub-id pub-id-type="doi">10.1006/dbio.2000.9732</pub-id>
<pub-id pub-id-type="pmid">10837119</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoelper</surname><given-names>D.</given-names></name><name><surname>Huang</surname><given-names>H.</given-names></name><name><surname>Jain</surname><given-names>A. Y.</given-names></name><name><surname>Patel</surname><given-names>D. J.</given-names></name><name><surname>Lewis</surname><given-names>P. W.</given-names></name></person-group> (<year>2017</year>). <article-title>Structural and mechanistic insights into ATRX-dependent and -independent functions of the histone chaperone DAXX.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>8</volume>:<issue>1193</issue>. <pub-id pub-id-type="doi">10.1038/s41467-017-01206-y</pub-id>
<pub-id pub-id-type="pmid">29084956</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffmann</surname><given-names>A.</given-names></name><name><surname>Spengler</surname><given-names>D.</given-names></name></person-group> (<year>2019</year>). <article-title>Chromatin remodeling complex NuRD in neurodevelopment and neurodevelopmental disorders.</article-title>
<source/><italic>Front. Genet.</italic>
<volume>10</volume>:<issue>682</issue>. <pub-id pub-id-type="doi">10.3389/fgene.2019.00682</pub-id>
<pub-id pub-id-type="pmid">31396263</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holmes</surname><given-names>L. B.</given-names></name><name><surname>Gang</surname><given-names>D. L.</given-names></name></person-group> (<year>1984</year>). <article-title>An X-linked mental retardation syndrome with craniofacial abnormalities, microcephaly and club foot.</article-title>
<source/><italic>Am. J. Med. Genet.</italic>
<volume>17</volume>
<fpage>375</fpage>–<lpage>382</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.1320170131</pub-id>
<pub-id pub-id-type="pmid">6711605</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Homann</surname><given-names>O. R.</given-names></name><name><surname>Misura</surname><given-names>K.</given-names></name><name><surname>Lamas</surname><given-names>E.</given-names></name><name><surname>Sandrock</surname><given-names>R. W.</given-names></name><name><surname>Nelson</surname><given-names>P.</given-names></name><name><surname>Mcdonough</surname><given-names>S. I.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Whole-genome sequencing in multiplex families with psychoses reveals mutations in the SHANK2 and SMARCA1 genes segregating with illness.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>21</volume>
<fpage>1690</fpage>–<lpage>1695</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2016.24.Whole-genome</pub-id><pub-id pub-id-type="pmid">27001614</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hood</surname><given-names>R. L.</given-names></name><name><surname>Lines</surname><given-names>M. A.</given-names></name><name><surname>Nikkel</surname><given-names>S. M.</given-names></name><name><surname>Schwartzentruber</surname><given-names>J.</given-names></name><name><surname>Beaulieu</surname><given-names>C.</given-names></name><name><surname>Nowaczyk</surname><given-names>M. J. M.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Mutations in SRCAP, encoding SNF2-related CREBBP activator protein, cause Floating-Harbor syndrome.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>90</volume>
<fpage>308</fpage>–<lpage>313</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2011.12.001</pub-id>
<pub-id pub-id-type="pmid">22265015</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hormozdiari</surname><given-names>F.</given-names></name><name><surname>Penn</surname><given-names>O.</given-names></name><name><surname>Borenstein</surname><given-names>E.</given-names></name><name><surname>Eichler</surname><given-names>E. E.</given-names></name></person-group> (<year>2015</year>). <article-title>The discovery of integrated gene networks for autism and related disorders.</article-title>
<source/><italic>Genome Res.</italic>
<volume>25</volume>
<fpage>142</fpage>–<lpage>154</lpage>. <pub-id pub-id-type="doi">10.1101/gr.178855.114.142</pub-id><pub-id pub-id-type="pmid">25378250</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hota</surname><given-names>S. K.</given-names></name><name><surname>Bruneau</surname><given-names>B. G.</given-names></name></person-group> (<year>2016</year>). <article-title>ATP-dependent chromatin remodeling during mammalian development.</article-title>
<source/><italic>Dev.</italic>
<volume>143</volume>
<fpage>2882</fpage>–<lpage>2897</lpage>. <pub-id pub-id-type="doi">10.1242/dev.128892</pub-id>
<pub-id pub-id-type="pmid">27531948</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howard</surname><given-names>M. T.</given-names></name><name><surname>Malik</surname><given-names>N.</given-names></name><name><surname>Anderson</surname><given-names>C. B.</given-names></name><name><surname>Voskuil</surname><given-names>J. L. A.</given-names></name><name><surname>Atkins</surname><given-names>J. F.</given-names></name><name><surname>Gibbons</surname><given-names>R. J.</given-names></name></person-group> (<year>2004</year>). <article-title>Attenuation of an amino-terminal premature stop codon mutation in the ATRX gene by an alternative mode of translational initiation.</article-title>
<source/><italic>J. Med. Genet.</italic>
<volume>41</volume>
<fpage>951</fpage>–<lpage>956</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.2004.020248</pub-id>
<pub-id pub-id-type="pmid">15591283</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoyer</surname><given-names>J.</given-names></name><name><surname>Ekici</surname><given-names>A. B.</given-names></name><name><surname>Endele</surname><given-names>S.</given-names></name><name><surname>Popp</surname><given-names>B.</given-names></name><name><surname>Zweier</surname><given-names>C.</given-names></name><name><surname>Wiesener</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Haploinsufficiency of ARID1B, a member of the SWI/SNF-A chromatin-remodeling complex, is a frequent cause of intellectual disability.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>90</volume>
<fpage>565</fpage>–<lpage>572</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2012.02.007</pub-id>
<pub-id pub-id-type="pmid">22405089</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huh</surname><given-names>M. S.</given-names></name><name><surname>Ivanochko</surname><given-names>D.</given-names></name><name><surname>Hashem</surname><given-names>L. E.</given-names></name><name><surname>Curtin</surname><given-names>M.</given-names></name><name><surname>Delorme</surname><given-names>M.</given-names></name><name><surname>Goodall</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Stalled replication forks within heterochromatin require ATRX for protection.</article-title>
<source/><italic>Cell Death Dis.</italic>
<volume>7</volume>
<fpage>1</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1038/cddis.2016.121</pub-id>
<pub-id pub-id-type="pmid">27171262</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huh</surname><given-names>M. S.</given-names></name><name><surname>O’Dea</surname><given-names>T. P.</given-names></name><name><surname>Ouazia</surname><given-names>D.</given-names></name><name><surname>McKay</surname><given-names>B. C.</given-names></name><name><surname>Parise</surname><given-names>G.</given-names></name><name><surname>Parks</surname><given-names>R. J.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Compromised genomic integrity impedes muscle growth after Atrx inactivation.</article-title>
<source/><italic>J. Clin. Invest.</italic>
<volume>122</volume>
<fpage>4412</fpage>–<lpage>4423</lpage>. <pub-id pub-id-type="doi">10.1172/JCI63765</pub-id>
<pub-id pub-id-type="pmid">23114596</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwase</surname><given-names>S.</given-names></name><name><surname>Xiang</surname><given-names>B.</given-names></name><name><surname>Ghosh</surname><given-names>S.</given-names></name><name><surname>Ren</surname><given-names>T.</given-names></name><name><surname>Lewis</surname><given-names>P. W.</given-names></name><name><surname>Cochrane</surname><given-names>J. C.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>ATRX ADD domain links an atypical histone methylation recognition mechanism to human mental-retardation syndrome.</article-title>
<source/><italic>Nat. Struct. Mol. Biol.</italic>
<volume>18</volume>
<fpage>769</fpage>–<lpage>776</lpage>. <pub-id pub-id-type="doi">10.1038/nsmb.2062</pub-id>
<pub-id pub-id-type="pmid">21666679</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jamain</surname><given-names>S.</given-names></name><name><surname>Quach</surname><given-names>H.</given-names></name><name><surname>Betancur</surname><given-names>C.</given-names></name><name><surname>Råstam</surname><given-names>M.</given-names></name><name><surname>Colineaux</surname><given-names>C.</given-names></name><name><surname>Gillberg</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>34</volume>
<fpage>27</fpage>–<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1038/ng1136</pub-id>
<pub-id pub-id-type="pmid">12669065</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karaca</surname><given-names>E.</given-names></name><name><surname>Harel</surname><given-names>T.</given-names></name><name><surname>Pehlivan</surname><given-names>D.</given-names></name><name><surname>Jhangiani</surname><given-names>S. N.</given-names></name><name><surname>Gambin</surname><given-names>T.</given-names></name><name><surname>Coban Akdemir</surname><given-names>Z.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Genes that affect brain structure and function identified by rare variant analyses of mendelian neurologic Disease.</article-title>
<source/><italic>Neuron</italic>
<volume>88</volume>
<fpage>499</fpage>–<lpage>513</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2015.09.048</pub-id>
<pub-id pub-id-type="pmid">26539891</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kleefstra</surname><given-names>T.</given-names></name><name><surname>Kramer</surname><given-names>J. M.</given-names></name><name><surname>Neveling</surname><given-names>K.</given-names></name><name><surname>Willemsen</surname><given-names>M. H.</given-names></name><name><surname>Koemans</surname><given-names>T. S.</given-names></name><name><surname>Vissers</surname><given-names>L. E. L. M.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Disruption of an EHMT1-associated chromatin-modification module causes intellectual disability.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>91</volume>
<fpage>73</fpage>–<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2012.05.003</pub-id>
<pub-id pub-id-type="pmid">22726846</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kochinke</surname><given-names>K.</given-names></name><name><surname>Zweier</surname><given-names>C.</given-names></name><name><surname>Nijhof</surname><given-names>B.</given-names></name><name><surname>Fenckova</surname><given-names>M.</given-names></name><name><surname>Cizek</surname><given-names>P.</given-names></name><name><surname>Honti</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Systematic phenomics analysis deconvolutes genes mutated in intellectual disability into biologically coherent modules.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>98</volume>
<fpage>149</fpage>–<lpage>164</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2015.11.024</pub-id>
<pub-id pub-id-type="pmid">26748517</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kosho</surname><given-names>T.</given-names></name><name><surname>Okamoto</surname><given-names>N.</given-names></name><name><surname>Ohashi</surname><given-names>H.</given-names></name><name><surname>Tsurusaki</surname><given-names>Y.</given-names></name><name><surname>Imai</surname><given-names>Y.</given-names></name><name><surname>Hibi-Ko</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Clinical correlations of mutations affecting six components of the SWI/SNF complex: detailed description of 21 patients and a review of the literature.</article-title>
<source/><italic>Am. J. Med. Genet. Part A</italic>
<volume>161</volume>
<fpage>1221</fpage>–<lpage>1237</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.35933</pub-id>
<pub-id pub-id-type="pmid">23637025</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kovatcheva</surname><given-names>M.</given-names></name><name><surname>Liao</surname><given-names>W.</given-names></name><name><surname>Klein</surname><given-names>M. E.</given-names></name><name><surname>Robine</surname><given-names>N.</given-names></name><name><surname>Geiger</surname><given-names>H.</given-names></name><name><surname>Crago</surname><given-names>A. M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>ATRX is a regulator of therapy induced senescence in human cells.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>8</volume>
<fpage>e540</fpage>–<lpage>e545</lpage>. <pub-id pub-id-type="doi">10.1038/s41467-017-00540-545</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lagali</surname><given-names>P. S.</given-names></name><name><surname>Medina</surname><given-names>C. F.</given-names></name><name><surname>Zhao</surname><given-names>B. Y. H.</given-names></name><name><surname>Yan</surname><given-names>K.</given-names></name><name><surname>Baker</surname><given-names>A. N.</given-names></name><name><surname>Coupland</surname><given-names>S. G.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Retinal interneuron survival requires non-cellautonomous Atrx activity.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>25</volume>
<fpage>4787</fpage>–<lpage>4803</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddw306</pub-id>
<pub-id pub-id-type="pmid">28173139</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laumonnier</surname><given-names>F.</given-names></name><name><surname>Bonnet-Brilhault</surname><given-names>F.</given-names></name><name><surname>Gomot</surname><given-names>M.</given-names></name><name><surname>Blanc</surname><given-names>R.</given-names></name><name><surname>David</surname><given-names>A.</given-names></name><name><surname>Moizard</surname><given-names>M. P.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>X-Linked mental retardation and autism are associated with a mutation in the NLGN4 Gene, a Member of the neuroligin family.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>74</volume>
<fpage>552</fpage>–<lpage>557</lpage>. <pub-id pub-id-type="doi">10.1086/382137</pub-id>
<pub-id pub-id-type="pmid">14963808</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Law</surname><given-names>M. J.</given-names></name><name><surname>Lower</surname><given-names>K. M.</given-names></name><name><surname>Voon</surname><given-names>H. P. J.</given-names></name><name><surname>Hughes</surname><given-names>J. R.</given-names></name><name><surname>Garrick</surname><given-names>D.</given-names></name><name><surname>Viprakasit</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>ATR-X syndrome protein targets tandem repeats and influences allele-specific expression in a size-dependent manner.</article-title>
<source/><italic>Cell</italic>
<volume>143</volume>
<fpage>367</fpage>–<lpage>378</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2010.09.023</pub-id>
<pub-id pub-id-type="pmid">21029860</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lechner</surname><given-names>M. S.</given-names></name><name><surname>Schultz</surname><given-names>D. C.</given-names></name><name><surname>Negorev</surname><given-names>D.</given-names></name><name><surname>Maul</surname><given-names>G. G.</given-names></name><name><surname>Rauscher</surname><given-names>F. J.</given-names></name></person-group> (<year>2005</year>). <article-title>The mammalian heterochromatin protein 1 binds diverse nuclear proteins through a common motif that targets the chromoshadow domain.</article-title>
<source/><italic>Biochem. Biophys. Res. Commun.</italic>
<volume>331</volume>
<fpage>929</fpage>–<lpage>937</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2005.04.016</pub-id>
<pub-id pub-id-type="pmid">15882967</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J. S.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Lim</surname><given-names>B. C.</given-names></name><name><surname>Kim</surname><given-names>K. J.</given-names></name><name><surname>Hwang</surname><given-names>Y. S.</given-names></name><name><surname>Choi</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Alpha-thalassemia X-linked intellectual disability syndrome identified by whole exome sequencing in two boys with white matter changes and developmental retardation.</article-title>
<source/><italic>Gene</italic>
<volume>569</volume>
<fpage>318</fpage>–<lpage>322</lpage>. <pub-id pub-id-type="doi">10.1016/j.gene.2015.04.075</pub-id>
<pub-id pub-id-type="pmid">25936994</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lessard</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>J. I.</given-names></name><name><surname>Ranish</surname><given-names>J. A.</given-names></name><name><surname>Wan</surname><given-names>M.</given-names></name><name><surname>Winslow</surname><given-names>M. M.</given-names></name><name><surname>Staahl</surname><given-names>B. T.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>An essential switch in subunit composition of a chromatin remodeling complex during neural development.</article-title>
<source/><italic>Neuron</italic>
<volume>55</volume>
<fpage>201</fpage>–<lpage>215</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2007.06.019.An</pub-id><pub-id pub-id-type="pmid">17640523</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>J. W. C.</given-names></name><name><surname>Ghosal</surname><given-names>G.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Shen</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Alpha thalassemia/mental retardation syndrome X-linked gene product ATRX is required for proper replication restart and cellular resistance to replication stress.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>288</volume>
<fpage>6342</fpage>–<lpage>6350</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M112.411603</pub-id>
<pub-id pub-id-type="pmid">23329831</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>M. A.</given-names></name><name><surname>Fernandes</surname><given-names>A. D.</given-names></name><name><surname>Tremblay</surname><given-names>D. C.</given-names></name><name><surname>Seah</surname><given-names>C.</given-names></name><name><surname>Bérubé</surname><given-names>N. G.</given-names></name></person-group> (<year>2008</year>). <article-title>The SWI/SNF protein ATRX co-regulates pseudoautosomal genes that have translocated to autosomes in the mouse genome.</article-title>
<source/><italic>BMC Genomics</italic>
<volume>9</volume>:<issue>468</issue>. <pub-id pub-id-type="doi">10.1186/1471-2164-9-468</pub-id>
<pub-id pub-id-type="pmid">18842153</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>M. A.</given-names></name><name><surname>Kernohan</surname><given-names>K. D.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Bérubé</surname><given-names>N. G.</given-names></name></person-group> (<year>2014</year>). <article-title>ATRX promotes gene expression by facilitating transcriptional elongation through guanine-rich coding regions.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>24</volume>
<fpage>1824</fpage>–<lpage>1835</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddu596</pub-id>
<pub-id pub-id-type="pmid">25452430</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>P. W.</given-names></name><name><surname>Elsaesser</surname><given-names>S. J.</given-names></name><name><surname>Noh</surname><given-names>K. M.</given-names></name><name><surname>Stadler</surname><given-names>S. C.</given-names></name><name><surname>Allis</surname><given-names>C. D.</given-names></name></person-group> (<year>2010</year>). <article-title>Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>107</volume>
<fpage>14075</fpage>–<lpage>14080</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1008850107</pub-id>
<pub-id pub-id-type="pmid">20651253</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopes</surname><given-names>F.</given-names></name><name><surname>Barbosa</surname><given-names>M.</given-names></name><name><surname>Ameur</surname><given-names>A.</given-names></name><name><surname>Soares</surname><given-names>G.</given-names></name><name><surname>De Sá</surname><given-names>J.</given-names></name><name><surname>Dias</surname><given-names>A. I.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Identification of novel genetic causes of Rett syndrome-like phenotypes.</article-title>
<source/><italic>J. Med. Genet.</italic>
<volume>53</volume>
<fpage>190</fpage>–<lpage>199</lpage>. <pub-id pub-id-type="doi">10.1136/jmedgenet-2015-103568</pub-id>
<pub-id pub-id-type="pmid">26740508</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lossi</surname><given-names>A. M.</given-names></name><name><surname>Millan</surname><given-names>J. M.</given-names></name><name><surname>Villard</surname><given-names>L.</given-names></name><name><surname>Orellana</surname><given-names>C.</given-names></name><name><surname>Cardoso</surname><given-names>C.</given-names></name><name><surname>Prieto</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>1999</year>). <article-title>Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding α-synudein [1].</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>65</volume>
<fpage>558</fpage>–<lpage>562</lpage>. <pub-id pub-id-type="doi">10.1086/302486</pub-id>
<pub-id pub-id-type="pmid">10417298</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lovejoy</surname><given-names>C. A.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Reisenweber</surname><given-names>S.</given-names></name><name><surname>Thongthip</surname><given-names>S.</given-names></name><name><surname>Bruno</surname><given-names>J.</given-names></name><name><surname>de Lange</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of Telomeres pathway.</article-title>
<source/><italic>PLoS Genet.</italic>
<volume>8</volume>:<issue>2772</issue>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1002772</pub-id>
<pub-id pub-id-type="pmid">22829774</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lovejoy</surname><given-names>C. A.</given-names></name><name><surname>Takai</surname><given-names>K.</given-names></name><name><surname>Huh</surname><given-names>M. S.</given-names></name><name><surname>Picketts</surname><given-names>D. J.</given-names></name><name><surname>de Lange</surname><given-names>T.</given-names></name></person-group> (<year>2020</year>). <article-title>ATRX affects the repair of telomeric DSBs by promoting cohesion and a DAXX-dependent activity.</article-title>
<source/><italic>PLoS Biol.</italic>
<volume>18</volume>:<issue>e3000594</issue>. <pub-id pub-id-type="doi">10.1371/journal.pbio.3000594</pub-id>
<pub-id pub-id-type="pmid">31895940</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>X.</given-names></name><name><surname>Meng</surname><given-names>X.</given-names></name><name><surname>Morris</surname><given-names>C. A.</given-names></name><name><surname>Keating</surname><given-names>M. T.</given-names></name></person-group> (<year>1998</year>). <article-title>A novel human gene, WSTF, is deleted in Williams syndrome.</article-title>
<source/><italic>Genomics</italic>
<volume>54</volume>
<fpage>241</fpage>–<lpage>249</lpage>. <pub-id pub-id-type="doi">10.1006/geno.1998.5578</pub-id>
<pub-id pub-id-type="pmid">9828126</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machol</surname><given-names>K.</given-names></name><name><surname>Rousseau</surname><given-names>J.</given-names></name><name><surname>Ehresmann</surname><given-names>S.</given-names></name><name><surname>Garcia</surname><given-names>T.</given-names></name><name><surname>Nguyen</surname><given-names>T. T. M.</given-names></name><name><surname>Spillmann</surname><given-names>R. C.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Expanding the spectrum of BAF-Related disorders: de novo variants in SMARCC2 Cause a syndrome with intellectual disability and developmental delay.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>104</volume>
<fpage>164</fpage>–<lpage>178</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2018.11.007</pub-id>
<pub-id pub-id-type="pmid">30580808</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maffia</surname><given-names>A.</given-names></name><name><surname>Ranise</surname><given-names>C.</given-names></name><name><surname>Sabbioneda</surname><given-names>S.</given-names></name></person-group> (<year>2020</year>). <article-title>From R-loops to G-quadruplexes: emerging new threats for the replication fork.</article-title>
<source/><italic>Int. J. Mol. Sci.</italic>
<volume>21</volume>:<issue>1506</issue>. <pub-id pub-id-type="doi">10.3390/ijms21041506</pub-id>
<pub-id pub-id-type="pmid">32098397</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maksakova</surname><given-names>I. A.</given-names></name><name><surname>Romanish</surname><given-names>M. T.</given-names></name><name><surname>Gagnier</surname><given-names>L.</given-names></name><name><surname>Dunn</surname><given-names>C. A.</given-names></name><name><surname>Van De Lagemaat</surname><given-names>L. N.</given-names></name><name><surname>Mager</surname><given-names>D. L.</given-names></name></person-group> (<year>2006</year>). <article-title>Retroviral elements and their hosts: insertional mutagenesis in the mouse germ line.</article-title>
<source/><italic>PLoS Genet.</italic>
<volume>2</volume>:<issue>2</issue>. <pub-id pub-id-type="doi">10.1371/journal.pgen.0020002</pub-id>
<pub-id pub-id-type="pmid">16440055</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDowell</surname><given-names>T. L.</given-names></name><name><surname>Gibbons</surname><given-names>R. J.</given-names></name><name><surname>Sutherland</surname><given-names>H.</given-names></name><name><surname>O’Rourke</surname><given-names>D. M.</given-names></name><name><surname>Bickmore</surname><given-names>W. A.</given-names></name><name><surname>Pombo</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>1999</year>). <article-title>Localization of a putative transcriptional regulator (ATRX) at pericentromeric heterochromatin and the short arms of acrocentric chromosomes.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>96</volume>
<fpage>13983</fpage>–<lpage>13988</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.96.24.13983</pub-id>
<pub-id pub-id-type="pmid">10570185</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medina</surname><given-names>C. F.</given-names></name><name><surname>Mazerolle</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Bérubé</surname><given-names>N. G.</given-names></name><name><surname>Coupland</surname><given-names>S.</given-names></name><name><surname>Gibbons</surname><given-names>R. J.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Altered visual function and interneuron survival in Atrx knockout mice: inference for the human syndrome.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>18</volume>
<fpage>966</fpage>–<lpage>977</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddn424</pub-id>
<pub-id pub-id-type="pmid">19088125</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitson</surname><given-names>M.</given-names></name><name><surname>Kelley</surname><given-names>L. A.</given-names></name><name><surname>Sternberg</surname><given-names>M. J. E.</given-names></name><name><surname>Higgs</surname><given-names>D. R.</given-names></name><name><surname>Gibbons</surname><given-names>R. J.</given-names></name></person-group> (<year>2011</year>). <article-title>Functional significance of mutations in the Snf2 domain of ATRX.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>20</volume>
<fpage>2603</fpage>–<lpage>2610</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddr163</pub-id>
<pub-id pub-id-type="pmid">21505078</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nan</surname><given-names>X.</given-names></name><name><surname>Hou</surname><given-names>J.</given-names></name><name><surname>Maclean</surname><given-names>A.</given-names></name><name><surname>Nasir</surname><given-names>J.</given-names></name><name><surname>Lafuente</surname><given-names>M. J.</given-names></name><name><surname>Shu</surname><given-names>X.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>104</volume>
<fpage>2709</fpage>–<lpage>2714</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0608056104</pub-id>
<pub-id pub-id-type="pmid">17296936</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neale</surname><given-names>B. M.</given-names></name><name><surname>Kou</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Ma’ayan</surname><given-names>A.</given-names></name><name><surname>Samocha</surname><given-names>K. E.</given-names></name><name><surname>Sabo</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Patterns and rates of exonic de novo mutations in autism spectrum disorders.</article-title>
<source/><italic>Nature</italic>
<volume>485</volume>:<issue>485</issue>. <pub-id pub-id-type="doi">10.1016/j.physbeh.2017.03.040</pub-id>
<pub-id pub-id-type="pmid">28363838</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>D. T.</given-names></name><name><surname>Voon</surname><given-names>H. P. J.</given-names></name><name><surname>Xella</surname><given-names>B.</given-names></name><name><surname>Scott</surname><given-names>C.</given-names></name><name><surname>Clynes</surname><given-names>D.</given-names></name><name><surname>Babbs</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>The chromatin remodelling factor ATRX suppresses R-loops in transcribed telomeric repeats.</article-title>
<source/><italic>EMBO Rep.</italic>
<volume>18</volume>
<fpage>914</fpage>–<lpage>928</lpage>. <pub-id pub-id-type="doi">10.15252/embr.201643078</pub-id>
<pub-id pub-id-type="pmid">28487353</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nitarska</surname><given-names>J.</given-names></name><name><surname>Smith</surname><given-names>J. G.</given-names></name><name><surname>Sherlock</surname><given-names>W. T.</given-names></name><name><surname>Hillege</surname><given-names>M. M. G.</given-names></name><name><surname>Nott</surname><given-names>A.</given-names></name><name><surname>Barshop</surname><given-names>W. D.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>A functional switch of NuRD chromatin remodeling complex subunits regulates mouse cortical development.</article-title>
<source/><italic>Cell Rep.</italic>
<volume>17</volume>
<fpage>1683</fpage>–<lpage>1698</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2016.10.022</pub-id>
<pub-id pub-id-type="pmid">27806305</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nogami</surname><given-names>T.</given-names></name><name><surname>Beppu</surname><given-names>H.</given-names></name><name><surname>Tokoro</surname><given-names>T.</given-names></name><name><surname>Moriguchi</surname><given-names>S.</given-names></name><name><surname>Shioda</surname><given-names>N.</given-names></name><name><surname>Fukunaga</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Reduced expression of the ATRX gene, a chromatin-remodeling factor, causes hippocampal dysfunction in mice.</article-title>
<source/><italic>Hippocampus</italic>
<volume>21</volume>
<fpage>678</fpage>–<lpage>687</lpage>. <pub-id pub-id-type="doi">10.1002/hipo.20782</pub-id>
<pub-id pub-id-type="pmid">20865721</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noh</surname><given-names>K. M.</given-names></name><name><surname>Maze</surname><given-names>I.</given-names></name><name><surname>Zhao</surname><given-names>D.</given-names></name><name><surname>Xiang</surname><given-names>B.</given-names></name><name><surname>Wenderski</surname><given-names>W.</given-names></name><name><surname>Lewis</surname><given-names>P. W.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>ATRX tolerates activity-dependent histone H3 methyl/phos switching to maintain repetitive element silencing in neurons.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>112</volume>
<fpage>6820</fpage>–<lpage>6827</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1411258112</pub-id>
<pub-id pub-id-type="pmid">25538301</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Roak</surname><given-names>B. J.</given-names></name><name><surname>Vives</surname><given-names>L.</given-names></name><name><surname>Fu</surname><given-names>W.</given-names></name><name><surname>Egertson</surname><given-names>J. D.</given-names></name><name><surname>Stanaway</surname><given-names>I. B.</given-names></name><name><surname>Phelps</surname><given-names>I. G.</given-names></name><etal></etal></person-group> (<year>2012a</year>). <article-title>Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders.</article-title>
<source/><italic>Science</italic>
<volume>338</volume>
<fpage>1619</fpage>–<lpage>1622</lpage>. <pub-id pub-id-type="doi">10.1007/978-4-431-56050-0_20</pub-id><pub-id pub-id-type="pmid">23160955</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Roak</surname><given-names>B. J.</given-names></name><name><surname>Vives</surname><given-names>L.</given-names></name><name><surname>Girirajan</surname><given-names>S.</given-names></name><name><surname>Karakoc</surname><given-names>E.</given-names></name><name><surname>Krumm</surname><given-names>N.</given-names></name><name><surname>Coe</surname><given-names>B. P.</given-names></name><etal></etal></person-group> (<year>2012b</year>). <article-title>Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations.</article-title>
<source/><italic>Nature</italic>
<volume>485</volume>
<fpage>246</fpage>–<lpage>250</lpage>. <pub-id pub-id-type="doi">10.1038/nature10989</pub-id>
<pub-id pub-id-type="pmid">22495309</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>J.</given-names></name><name><surname>Lee</surname><given-names>H.</given-names></name><name><surname>Han</surname><given-names>N.</given-names></name><name><surname>Kwak</surname><given-names>S.</given-names></name><name><surname>Lee</surname><given-names>H. T.</given-names></name><name><surname>Kim</surname><given-names>J. H.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Long non-coding RNA ChRO1 facilitates ATRX/DAXX-dependent H3.3 deposition for transcription-associated heterochromatin reorganization.</article-title>
<source/><italic>Nucleic Acids Res.</italic>
<volume>46</volume>
<fpage>11759</fpage>–<lpage>11775</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gky923</pub-id>
<pub-id pub-id-type="pmid">30335163</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peoples</surname><given-names>R. J.</given-names></name><name><surname>Cisco</surname><given-names>M. J.</given-names></name><name><surname>Kaplan</surname><given-names>P.</given-names></name><name><surname>Francke</surname><given-names>U.</given-names></name></person-group> (<year>1998</year>). <article-title>Identification of the WBSCR9 gene, encoding a novel transcriptional regulator, in the Williams-Beuren syndrome deletion at 7q11.<italic>23</italic>.</article-title>
<source/><italic>Cytogenet. Cell Genet.</italic>
<volume>82</volume>
<fpage>238</fpage>–<lpage>246</lpage>. <pub-id pub-id-type="doi">10.1159/000015110</pub-id>
<pub-id pub-id-type="pmid">9858827</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>C. L.</given-names></name></person-group> (<year>2009</year>). <article-title>Reconstitution of nucleosomal arrays using recombinant Drosophila ACF and NAP1.</article-title>
<source/><italic>Cold Spring Harb. Protoc.</italic>
<volume>4</volume>
<fpage>1</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1101/pdb.prot5114</pub-id>
<pub-id pub-id-type="pmid">20147123</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pickett</surname><given-names>H. A.</given-names></name><name><surname>Reddel</surname><given-names>R. R.</given-names></name></person-group> (<year>2015</year>). <article-title>Molecular mechanisms of activity and derepression of alternative lengthening of telomeres.</article-title>
<source/><italic>Nat. Struct. Mol. Biol.</italic>
<volume>22</volume>
<fpage>875</fpage>–<lpage>880</lpage>. <pub-id pub-id-type="doi">10.1038/nsmb.3106</pub-id>
<pub-id pub-id-type="pmid">26581522</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Picketts</surname><given-names>D. J.</given-names></name><name><surname>Higgs</surname><given-names>D. R.</given-names></name><name><surname>Bachoo</surname><given-names>S.</given-names></name><name><surname>Blake</surname><given-names>D. J.</given-names></name><name><surname>Quarrell</surname><given-names>O. W. J.</given-names></name><name><surname>Gibbons</surname><given-names>R. J.</given-names></name></person-group> (<year>1996</year>). <article-title>ATRX encodes a novel member of the SNF2 family of proteins: mutations point to a common mechanism underlying the ATR-X syndrome.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>5</volume>
<fpage>1899</fpage>–<lpage>1907</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/5.12.1899</pub-id>
<pub-id pub-id-type="pmid">8968741</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Picketts</surname><given-names>D. J.</given-names></name><name><surname>Tastan</surname><given-names>A. O.</given-names></name><name><surname>Higgs</surname><given-names>D. R.</given-names></name><name><surname>Gibbons</surname><given-names>R. J.</given-names></name></person-group> (<year>1998</year>). <article-title>Comparison of the human and murine ATRX gene identifies highly conserved, functionally important domains.</article-title>
<source/><italic>Mamm. Genome</italic>
<volume>9</volume>
<fpage>400</fpage>–<lpage>403</lpage>. <pub-id pub-id-type="doi">10.1007/s003359900781</pub-id>
<pub-id pub-id-type="pmid">9545503</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pisansky</surname><given-names>M. T.</given-names></name><name><surname>Young</surname><given-names>A. E.</given-names></name><name><surname>O’Connor</surname><given-names>M. B.</given-names></name><name><surname>Gottesman</surname><given-names>I. I.</given-names></name><name><surname>Bagchi</surname><given-names>A.</given-names></name><name><surname>Gewirtz</surname><given-names>J. C.</given-names></name></person-group> (<year>2017</year>). <article-title>Mice lacking the chromodomain helicase DNA-binding 5 chromatin remodeler display autism-like characteristics.</article-title>
<source/><italic>Transl. Psychiatry</italic>
<volume>7</volume>:<issue>e1152</issue>. <pub-id pub-id-type="doi">10.1038/tp.2017.111</pub-id>
<pub-id pub-id-type="pmid">28608855</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>W.</given-names></name><name><surname>Medeiros</surname><given-names>N.</given-names></name><name><surname>Warneford-Thomson</surname><given-names>R.</given-names></name><name><surname>Wulfridge</surname><given-names>P.</given-names></name><name><surname>Yan</surname><given-names>Q.</given-names></name><name><surname>Bian</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2020</year>). <article-title>Disruption of ATRX-RNA interactions uncovers roles in ATRX localization and PRC2 function.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>11</volume>:<issue>2219</issue>
<pub-id pub-id-type="doi">10.1038/s41467-020-15902-15909</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhodes</surname><given-names>D.</given-names></name><name><surname>Lipps</surname><given-names>H. J.</given-names></name></person-group> (<year>2015</year>). <article-title>Survey and summary G-quadruplexes and their regulatory roles in biology.</article-title>
<source/><italic>Nucleic Acids Res.</italic>
<volume>43</volume>
<fpage>8627</fpage>–<lpage>8637</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkv862</pub-id>
<pub-id pub-id-type="pmid">26350216</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribeiro de Almeida</surname><given-names>C.</given-names></name><name><surname>Dhir</surname><given-names>S.</given-names></name><name><surname>Dhir</surname><given-names>A.</given-names></name><name><surname>Moghaddam</surname><given-names>A. E.</given-names></name><name><surname>Sattentau</surname><given-names>Q.</given-names></name><name><surname>Meinhart</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>RNA Helicase DDX1 converts RNA G-quadruplex structures into R-loops to promote IgH class switch recombination.</article-title>
<source/><italic>Mol. Cell</italic>
<volume>70</volume>
<fpage>650</fpage>–<lpage>662</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2018.04.001</pub-id>
<pub-id pub-id-type="pmid">29731414</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritchie</surname><given-names>K.</given-names></name><name><surname>Seah</surname><given-names>C.</given-names></name><name><surname>Moulin</surname><given-names>J.</given-names></name><name><surname>Isaac</surname><given-names>C.</given-names></name><name><surname>Dick</surname><given-names>F.</given-names></name><name><surname>Bérubé</surname><given-names>N. G.</given-names></name></person-group> (<year>2008</year>). <article-title>Loss of ATRX leads to chromosome cohesion and congression defects.</article-title>
<source/><italic>J. Cell Biol.</italic>
<volume>180</volume>
<fpage>315</fpage>–<lpage>324</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200706083</pub-id>
<pub-id pub-id-type="pmid">18227278</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritchie</surname><given-names>K.</given-names></name><name><surname>Watson</surname><given-names>L. A.</given-names></name><name><surname>Davidson</surname><given-names>B.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Bérubé</surname><given-names>N. G.</given-names></name></person-group> (<year>2014</year>). <article-title>ATRX is required for maintenance of the neuroprogenitor cell pool in the embryonic mouse brain.</article-title>
<source/><italic>Biol. Open</italic>
<volume>3</volume>
<fpage>1158</fpage>–<lpage>1163</lpage>. <pub-id pub-id-type="doi">10.1242/bio.20148730</pub-id>
<pub-id pub-id-type="pmid">25395668</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ronan</surname><given-names>J. L.</given-names></name><name><surname>Wu</surname><given-names>W.</given-names></name><name><surname>Crabtree</surname><given-names>G. R.</given-names></name></person-group> (<year>2013</year>). <article-title>From neural development to cognition: unexpected roles for chromatin.</article-title>
<source/><italic>Nat Rev Genet</italic>
<volume>14</volume>
<fpage>347</fpage>–<lpage>359</lpage>. <pub-id pub-id-type="doi">10.1038/jid.2014.371</pub-id>
<pub-id pub-id-type="pmid">23568486</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadic</surname><given-names>D.</given-names></name><name><surname>Schmidt</surname><given-names>K.</given-names></name><name><surname>Groh</surname><given-names>S.</given-names></name><name><surname>Kondofersky</surname><given-names>I.</given-names></name><name><surname>Ellwart</surname><given-names>J.</given-names></name><name><surname>Fuchs</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Atrx promotes heterochromatin formation at retrotransposons.</article-title>
<source/><italic>EMBO Rep.</italic>
<volume>16</volume>
<fpage>836</fpage>–<lpage>850</lpage>. <pub-id pub-id-type="doi">10.15252/embr.201439937</pub-id>
<pub-id pub-id-type="pmid">26012739</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanlaville</surname><given-names>D.</given-names></name><name><surname>Etchevers</surname><given-names>H. C.</given-names></name><name><surname>Gonzales</surname><given-names>M.</given-names></name><name><surname>Martinovic</surname><given-names>J.</given-names></name><name><surname>Clément-Ziza</surname><given-names>M.</given-names></name><name><surname>Delezoide</surname><given-names>A. L.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Phenotypic spectrum of CHARGE syndrome in fetuses with CHD7 truncating mutations correlates with expression during human development.</article-title>
<source/><italic>J. Med. Genet.</italic>
<volume>43</volume>
<fpage>211</fpage>–<lpage>217</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.2005.036160</pub-id>
<pub-id pub-id-type="pmid">16169932</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santen</surname><given-names>G. W. E.</given-names></name><name><surname>Aten</surname><given-names>E.</given-names></name><name><surname>Sun</surname><given-names>Y.</given-names></name><name><surname>Almomani</surname><given-names>R.</given-names></name><name><surname>Gilissen</surname><given-names>C.</given-names></name><name><surname>Nielsen</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Mutations in SWI/SNF chromatin remodeling complex gene ARID1B cause Coffin-Siris syndrome.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>44</volume>
<fpage>379</fpage>–<lpage>380</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2217</pub-id>
<pub-id pub-id-type="pmid">22426309</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santen</surname><given-names>G. W. E.</given-names></name><name><surname>Aten</surname><given-names>E.</given-names></name><name><surname>Vulto-van Silfhout</surname><given-names>A. T.</given-names></name><name><surname>Pottinger</surname><given-names>C.</given-names></name><name><surname>van Bon</surname><given-names>B. W. M.</given-names></name><name><surname>van Minderhout</surname><given-names>I. J. H. M.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Coffin-siris syndrome and the BAF complex: genotype-phenotype study in 63 patients.</article-title>
<source/><italic>Hum. Mutat.</italic>
<volume>34</volume>
<fpage>1519</fpage>–<lpage>1528</lpage>. <pub-id pub-id-type="doi">10.1002/humu.22394</pub-id>
<pub-id pub-id-type="pmid">23929686</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarma</surname><given-names>K.</given-names></name><name><surname>Cifuentes-Rojas</surname><given-names>C.</given-names></name><name><surname>Ergun</surname><given-names>A.</given-names></name><name><surname>del Rosario</surname><given-names>A.</given-names></name><name><surname>Jeon</surname><given-names>Y.</given-names></name><name><surname>White</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>ATRX directs binding of PRC2 to Xist RNA and polycomb targets.</article-title>
<source/><italic>Cell</italic>
<volume>159</volume>
<fpage>869</fpage>–<lpage>883</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2014.10.019</pub-id>
<pub-id pub-id-type="pmid">25417162</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satterstrom</surname><given-names>F. K.</given-names></name><name><surname>Kosmicki</surname><given-names>J. A.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Breen</surname><given-names>M. S.</given-names></name></person-group> (<year>2020</year>). <article-title>Large-scale exome sequencing study implicates both developmental and functional changes in the neurobiology of autism.</article-title>
<source/><italic>Cell</italic>
<volume>180</volume>
<fpage>568</fpage>–<lpage>584</lpage>.<pub-id pub-id-type="pmid">31981491</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saugier-Veber</surname><given-names>P.</given-names></name><name><surname>Munnich</surname><given-names>A.</given-names></name><name><surname>Lyonnet</surname><given-names>S.</given-names></name><name><surname>Toutain</surname><given-names>A.</given-names></name><name><surname>Moraine</surname><given-names>C.</given-names></name><name><surname>Piussan</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>1995</year>). <article-title>Lumping Juberg-Marsidi syndrome and X-linked alpha-thalassemia/mental retardation syndrome?</article-title>
<source/><italic>Am. J. Med. Genet.</italic>
<volume>55</volume>
<fpage>300</fpage>–<lpage>301</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.1320550310</pub-id>
<pub-id pub-id-type="pmid">7726226</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartzentruber</surname><given-names>J.</given-names></name><name><surname>Korshunov</surname><given-names>A.</given-names></name><name><surname>Liu</surname><given-names>X. Y.</given-names></name><name><surname>Jones</surname><given-names>D. T. W.</given-names></name><name><surname>Pfaff</surname><given-names>E.</given-names></name><name><surname>Jacob</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma.</article-title>
<source/><italic>Nature</italic>
<volume>482</volume>
<fpage>226</fpage>–<lpage>231</lpage>. <pub-id pub-id-type="doi">10.1038/nature10833</pub-id>
<pub-id pub-id-type="pmid">22286061</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>T.</given-names></name><name><surname>Guo</surname><given-names>H.</given-names></name><name><surname>Eichler</surname><given-names>E.</given-names></name><name><surname>Rosenfeld</surname><given-names>J.</given-names></name><name><surname>Pang</surname><given-names>K.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><etal></etal></person-group> (<year>2020</year>). <article-title>BAZ2B haploinsufficiency as a cause of developmental delay, intellectual disability, and autism spectrum disorder.</article-title>
<source/><italic>Hum. Mutat.</italic>
<volume>41</volume>
<fpage>921</fpage>–<lpage>925</lpage>.<pub-id pub-id-type="pmid">31999386</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shang</surname><given-names>L.</given-names></name><name><surname>Cho</surname><given-names>M. T.</given-names></name><name><surname>Retterer</surname><given-names>K.</given-names></name><name><surname>Folk</surname><given-names>L.</given-names></name><name><surname>Humberson</surname><given-names>J.</given-names></name><name><surname>Rohena</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Mutations in ARID2 are associated with intellectual disabilities.</article-title>
<source/><italic>Neurogenetics</italic>
<volume>16</volume>
<fpage>307</fpage>–<lpage>314</lpage>. <pub-id pub-id-type="doi">10.1007/s10048-015-0454-450</pub-id><pub-id pub-id-type="pmid">26238514</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shioda</surname><given-names>N.</given-names></name><name><surname>Beppu</surname><given-names>H.</given-names></name><name><surname>Fukuda</surname><given-names>T.</given-names></name><name><surname>Li</surname><given-names>E.</given-names></name><name><surname>Kitajima</surname><given-names>I.</given-names></name><name><surname>Fukunaga</surname><given-names>K.</given-names></name></person-group> (<year>2011</year>). <article-title>Aberrant calcium/calmodulin-dependent protein kinase II (CaMKII) activity is associated with abnormal dendritic spine morphology in the ATRX mutant mouse brain.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>31</volume>
<fpage>346</fpage>–<lpage>358</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4816-10.2011</pub-id>
<pub-id pub-id-type="pmid">21209221</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shioda</surname><given-names>N.</given-names></name><name><surname>Yabuki</surname><given-names>Y.</given-names></name><name><surname>Yamaguchi</surname><given-names>K.</given-names></name><name><surname>Onozato</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Kurosawa</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Targeting G-quadruplex DNA as cognitive function therapy for ATR-X syndrome article.</article-title>
<source/><italic>Nat. Med.</italic>
<volume>24</volume>
<fpage>802</fpage>–<lpage>813</lpage>. <pub-id pub-id-type="doi">10.1038/s41591-018-0018-6</pub-id>
<pub-id pub-id-type="pmid">29785027</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snijders Blok</surname><given-names>L.</given-names></name><name><surname>Rousseau</surname><given-names>J.</given-names></name><name><surname>Twist</surname><given-names>J.</given-names></name><name><surname>Ehresmann</surname><given-names>S.</given-names></name><name><surname>Takaku</surname><given-names>M.</given-names></name><name><surname>Venselaar</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>CHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>9</volume>
<fpage>1</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1038/s41467-018-06014-6016</pub-id><pub-id pub-id-type="pmid">29317637</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sokpor</surname><given-names>G.</given-names></name><name><surname>Xie</surname><given-names>Y.</given-names></name><name><surname>Rosenbusch</surname><given-names>J.</given-names></name><name><surname>Tuoc</surname><given-names>T.</given-names></name></person-group> (<year>2017</year>). <article-title>Chromatin remodeling BAF (SWI/SNF) complexes in neural development and disorders.</article-title>
<source/><italic>Front. Mol. Neurosci.</italic>
<volume>10</volume>:<issue>243</issue>. <pub-id pub-id-type="doi">10.3389/fnmol.2017.00243</pub-id>
<pub-id pub-id-type="pmid">28824374</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solomon</surname><given-names>L. A.</given-names></name><name><surname>Li</surname><given-names>J. R.</given-names></name><name><surname>Bérubé</surname><given-names>N. G.</given-names></name><name><surname>Beier</surname><given-names>F.</given-names></name></person-group> (<year>2009</year>). <article-title>Loss of ATRX in chondrocytes has minimal effects on skeletal development.</article-title>
<source/><italic>PLoS One</italic>
<volume>4</volume>:<issue>7106</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0007106</pub-id>
<pub-id pub-id-type="pmid">19774083</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solomon</surname><given-names>L. A.</given-names></name><name><surname>Russell</surname><given-names>B. A.</given-names></name><name><surname>Makar</surname><given-names>D.</given-names></name><name><surname>Bérubé</surname><given-names>N. G.</given-names></name><name><surname>Beier</surname><given-names>F.</given-names></name></person-group> (<year>2013</year>). <article-title>Loss of ATRX does not confer susceptibility to osteoarthritis.</article-title>
<source/><italic>PLoS One</italic>
<volume>8</volume>:<issue>85526</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0085526</pub-id>
<pub-id pub-id-type="pmid">24386478</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stankiewicz</surname><given-names>P.</given-names></name><name><surname>Khan</surname><given-names>T. N.</given-names></name><name><surname>Szafranski</surname><given-names>P.</given-names></name><name><surname>Slattery</surname><given-names>L.</given-names></name><name><surname>Streff</surname><given-names>H.</given-names></name><name><surname>Vetrini</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Haploinsufficiency of the chromatin remodeler BPTF causes syndromic developmental and speech delay, postnatal microcephaly, and dysmorphic features.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>101</volume>
<fpage>503</fpage>–<lpage>515</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2017.08.014</pub-id>
<pub-id pub-id-type="pmid">28942966</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>X.</given-names></name><name><surname>Morozova</surname><given-names>T.</given-names></name><name><surname>Sonnenfeld</surname><given-names>M.</given-names></name></person-group> (<year>2006</year>). <article-title>Glial and neuronal functions of the Drosophila homolog of the human SWI/SNF gene ATR-X (DATR-X) and the jing zinc-finger gene specify the lateral positioning of longitudinal glia and axons.</article-title>
<source/><italic>Genetics</italic>
<volume>173</volume>
<fpage>1397</fpage>–<lpage>1415</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.106.057893</pub-id>
<pub-id pub-id-type="pmid">16648585</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamming</surname><given-names>R. J.</given-names></name><name><surname>Siu</surname><given-names>J. R.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Prado</surname><given-names>M. A. M.</given-names></name><name><surname>Beier</surname><given-names>F.</given-names></name><name><surname>Bérubé</surname><given-names>N. G.</given-names></name></person-group> (<year>2017</year>). <article-title>Mosaic expression of Atrx in the mouse central nervous system causes memory deficits.</article-title>
<source/><italic>DMM Dis. Model. Mech.</italic>
<volume>10</volume>
<fpage>119</fpage>–<lpage>126</lpage>. <pub-id pub-id-type="doi">10.1242/dmm.027482</pub-id>
<pub-id pub-id-type="pmid">28093507</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>S.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Stratt</surname><given-names>R.</given-names></name><name><surname>Barak</surname><given-names>O. G.</given-names></name><name><surname>Shiekhattar</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>A novel transcription regulatory complex containing death domain-associated protein and the ATR-X Syndrome protein.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>279</volume>
<fpage>20369</fpage>–<lpage>20377</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M401321200</pub-id>
<pub-id pub-id-type="pmid">14990586</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torigoe</surname><given-names>S. E.</given-names></name><name><surname>Urwin</surname><given-names>D. L.</given-names></name><name><surname>Ishii</surname><given-names>H.</given-names></name><name><surname>Smith</surname><given-names>D. E.</given-names></name><name><surname>Kadonaga</surname><given-names>J. T.</given-names></name></person-group> (<year>2011</year>). <article-title>Identification of a rapidly formed nonnucleosomal histone-DNA intermediate that is converted into chromatin by ACF.</article-title>
<source/><italic>Mol. Cell</italic>
<volume>43</volume>
<fpage>638</fpage>–<lpage>648</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2011.07.017</pub-id>
<pub-id pub-id-type="pmid">21855802</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toubiana</surname><given-names>S.</given-names></name><name><surname>Selig</surname><given-names>S.</given-names></name></person-group> (<year>2018</year>). <article-title>DNA:RNA hybrids at telomeres - when it is better to be out of the (R) loop.</article-title>
<source/><italic>FEBS J.</italic>
<volume>285</volume>
<fpage>2552</fpage>–<lpage>2566</lpage>. <pub-id pub-id-type="doi">10.1111/febs.14464</pub-id>
<pub-id pub-id-type="pmid">29637701</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsurusaki</surname><given-names>Y.</given-names></name><name><surname>Koshimizu</surname><given-names>E.</given-names></name><name><surname>Ohashi</surname><given-names>H.</given-names></name><name><surname>Phadke</surname><given-names>S.</given-names></name><name><surname>Kou</surname><given-names>I.</given-names></name><name><surname>Shiina</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2014a</year>). <article-title>De novo SOX11 mutations cause Coffin-Siris syndrome.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>5</volume>
<fpage>1</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1038/ncomms5011</pub-id>
<pub-id pub-id-type="pmid">24886874</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsurusaki</surname><given-names>Y.</given-names></name><name><surname>Okamoto</surname><given-names>N.</given-names></name><name><surname>Ohashi</surname><given-names>H.</given-names></name><name><surname>Mizuno</surname><given-names>S.</given-names></name><name><surname>Matsumoto</surname><given-names>N.</given-names></name><name><surname>Makita</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2014b</year>). <article-title>Coffin-Siris syndrome is a SWI/SNF complex disorder.</article-title>
<source/><italic>Clin. Genet.</italic>
<volume>85</volume>
<fpage>548</fpage>–<lpage>554</lpage>. <pub-id pub-id-type="doi">10.1111/cge.12225</pub-id>
<pub-id pub-id-type="pmid">23815551</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsurusaki</surname><given-names>Y.</given-names></name><name><surname>Okamoto</surname><given-names>N.</given-names></name><name><surname>Ohashi</surname><given-names>H.</given-names></name><name><surname>Kosho</surname><given-names>T.</given-names></name><name><surname>Imai</surname><given-names>Y.</given-names></name><name><surname>Hibi-Ko</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>44</volume>
<fpage>376</fpage>–<lpage>378</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2219</pub-id>
<pub-id pub-id-type="pmid">22426308</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Udugama</surname><given-names>M.</given-names></name><name><surname>Chang</surname><given-names>F. T. M.</given-names></name><name><surname>Chan</surname><given-names>F. L.</given-names></name><name><surname>Tang</surname><given-names>M. C.</given-names></name><name><surname>Pickett</surname><given-names>H. A.</given-names></name><name><surname>McGhie</surname><given-names>J. D. R.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Histone variant H3.3 provides the heterochromatic <italic>H</italic>3 lysine 9 tri-methylation mark at telomeres.</article-title>
<source/><italic>Nucleic Acids Res.</italic>
<volume>43</volume>
<fpage>10227</fpage>–<lpage>10237</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkv847</pub-id>
<pub-id pub-id-type="pmid">26304540</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valton</surname><given-names>A. L.</given-names></name><name><surname>Prioleau</surname><given-names>M. N.</given-names></name></person-group> (<year>2016</year>). <article-title>G-Quadruplexes in DNA replication: a problem or a necessity?</article-title>
<source/><italic>Trends Genet.</italic>
<volume>32</volume>
<fpage>697</fpage>–<lpage>706</lpage>. <pub-id pub-id-type="doi">10.1016/j.tig.2016.09.004</pub-id>
<pub-id pub-id-type="pmid">27663528</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Sluijs</surname><given-names>P. J.</given-names></name><name><surname>Jansen</surname><given-names>S.</given-names></name><name><surname>Vergano</surname><given-names>S. A.</given-names></name><name><surname>Adachi-Fukuda</surname><given-names>M.</given-names></name><name><surname>Alanay</surname><given-names>Y.</given-names></name><name><surname>AlKindy</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>The ARID1B spectrum in 143 patients: from nonsyndromic intellectual disability to Coffin-Siris syndrome.</article-title>
<source/><italic>Genet. Med.</italic>
<volume>21</volume>
<fpage>1295</fpage>–<lpage>1307</lpage>. <pub-id pub-id-type="doi">10.1038/s41436-018-0330-z</pub-id>
<pub-id pub-id-type="pmid">30349098</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Houdt</surname><given-names>J. K. J.</given-names></name><name><surname>Nowakowska</surname><given-names>B. A.</given-names></name><name><surname>Sousa</surname><given-names>S. B.</given-names></name><name><surname>Van Schaik</surname><given-names>B. D. C.</given-names></name><name><surname>Seuntjens</surname><given-names>E.</given-names></name><name><surname>Avonce</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Heterozygous missense mutations in SMARCA2 cause nicolaides-baraitser syndrome.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>44</volume>
<fpage>445</fpage>–<lpage>449</lpage>. <pub-id pub-id-type="doi">10.1038/ng.1105</pub-id>
<pub-id pub-id-type="pmid">22366787</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varshney</surname><given-names>D.</given-names></name><name><surname>Spiegel</surname><given-names>J.</given-names></name><name><surname>Zyner</surname><given-names>K.</given-names></name><name><surname>Tannahill</surname><given-names>D.</given-names></name><name><surname>Balasubramanian</surname><given-names>S.</given-names></name></person-group> (<year>2020</year>). <article-title>The regulation and functions of DNA and RNA G-quadruplexes.</article-title>
<source/><italic>Nat. Rev. Mol. Cell Biol.</italic>
<volume>21</volume>
<fpage>459</fpage>–<lpage>474</lpage>. <pub-id pub-id-type="doi">10.1038/s41580-020-0236-x</pub-id>
<pub-id pub-id-type="pmid">32313204</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasileiou</surname><given-names>G.</given-names></name><name><surname>Vergarajauregui</surname><given-names>S.</given-names></name><name><surname>Endele</surname><given-names>S.</given-names></name><name><surname>Popp</surname><given-names>B.</given-names></name><name><surname>Büttner</surname><given-names>C.</given-names></name><name><surname>Ekici</surname><given-names>A. B.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Mutations in the BAF-complex subunit DPF2 are associated with coffin-siris syndrome.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>102</volume>
<fpage>468</fpage>–<lpage>479</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2018.01.014</pub-id>
<pub-id pub-id-type="pmid">29429572</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>P.</given-names></name><name><surname>Greenberg</surname><given-names>R. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Noncanonical views of homology-directed DNA repair.</article-title>
<source/><italic>Genes Dev.</italic>
<volume>30</volume>
<fpage>1138</fpage>–<lpage>1154</lpage>. <pub-id pub-id-type="doi">10.1101/gad.280545.116</pub-id>
<pub-id pub-id-type="pmid">27222516</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vissers</surname><given-names>L. E. L. M.</given-names></name><name><surname>Van Ravenswaaij</surname><given-names>C. M. A.</given-names></name><name><surname>Admiraal</surname><given-names>R.</given-names></name><name><surname>Hurst</surname><given-names>J. A.</given-names></name><name><surname>De Vries</surname><given-names>B. B. A.</given-names></name><name><surname>Janssen</surname><given-names>I. M.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Mutations in a new member of the chromodomain gene family cause CHARGE syndrome.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>36</volume>
<fpage>955</fpage>–<lpage>957</lpage>. <pub-id pub-id-type="doi">10.1038/ng1407</pub-id>
<pub-id pub-id-type="pmid">15300250</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voon</surname><given-names>H. P. J.</given-names></name><name><surname>Hughes</surname><given-names>J. R.</given-names></name><name><surname>Rode</surname><given-names>C.</given-names></name><name><surname>DeLaRosa-Velázquez</surname><given-names>I. A.</given-names></name><name><surname>Jenuwein</surname><given-names>T.</given-names></name><name><surname>Feil</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>ATRX plays a key role in maintaining silencing at interstitial heterochromatic loci and imprinted genes.</article-title>
<source/><italic>Cell Rep.</italic>
<volume>11</volume>
<fpage>405</fpage>–<lpage>418</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2015.03.036</pub-id>
<pub-id pub-id-type="pmid">25865896</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wada</surname><given-names>T.</given-names></name><name><surname>Ban</surname><given-names>H.</given-names></name><name><surname>Matsufuji</surname><given-names>M.</given-names></name><name><surname>Okamoto</surname><given-names>N.</given-names></name><name><surname>Enomoto</surname><given-names>K.</given-names></name><name><surname>Kurosawa</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Neuroradiologic features in α-linked α-thalassemia/mental retardation syndrome.</article-title>
<source/><italic>Am. J. Neuroradiol.</italic>
<volume>34</volume>
<fpage>2034</fpage>–<lpage>2038</lpage>. <pub-id pub-id-type="doi">10.3174/ajnr.A3560</pub-id>
<pub-id pub-id-type="pmid">23681356</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>L. A.</given-names></name><name><surname>Goldberg</surname><given-names>H.</given-names></name><name><surname>Berube</surname><given-names>N. G.</given-names></name></person-group> (<year>2015</year>). <article-title>Emerging roles of ATRX in cancer.</article-title>
<source/><italic>Epigenomics</italic>
<volume>7</volume>
<fpage>1365</fpage>–<lpage>1378</lpage>. <pub-id pub-id-type="doi">10.2217/epi.15.82</pub-id>
<pub-id pub-id-type="pmid">26646632</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>L. A.</given-names></name><name><surname>Solomon</surname><given-names>L. A.</given-names></name><name><surname>Li</surname><given-names>J. R.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Edwards</surname><given-names>M.</given-names></name><name><surname>Shin-Ya</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Atrx deficiency induces telomere dysfunction, endocrine defects, and reduced life span.</article-title>
<source/><italic>J. Clin. Invest.</italic>
<volume>123</volume>
<fpage>2049</fpage>–<lpage>2063</lpage>. <pub-id pub-id-type="doi">10.1172/JCI65634</pub-id>
<pub-id pub-id-type="pmid">23563309</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>K.</given-names></name><name><surname>Lazar</surname><given-names>H. P.</given-names></name><name><surname>Kurolap</surname><given-names>A.</given-names></name><name><surname>Martinez</surname><given-names>A. F.</given-names></name><name><surname>Paperna</surname><given-names>T.</given-names></name><name><surname>Cohen</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2020</year>). <article-title>Correction: the CHD4-related syndrome: a comprehensive investigation of the clinical spectrum, genotype-phenotype correlations, and molecular basis (Genetics in Medicine, (2020), 22, 2, (389-397), 10.1038/s41436-019-0612-0).</article-title>
<source/><italic>Genet. Med.</italic>
<volume>22</volume>:<issue>669</issue>. <pub-id pub-id-type="doi">10.1038/s41436-019-0727-3</pub-id>
<pub-id pub-id-type="pmid">31844176</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wieczorek</surname><given-names>D.</given-names></name><name><surname>Bögershausen</surname><given-names>N.</given-names></name><name><surname>Beleggia</surname><given-names>F.</given-names></name><name><surname>Steiner-Haldenstätt</surname><given-names>S.</given-names></name><name><surname>Pohl</surname><given-names>E.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>A comprehensive molecular study on coffin-siris and nicolaides-baraitser syndromes identifies a broad molecular and clinical spectrum converging on altered chromatin remodeling.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>22</volume>
<fpage>5121</fpage>–<lpage>5135</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddt366</pub-id>
<pub-id pub-id-type="pmid">23906836</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>L. H.</given-names></name><name><surname>McGhie</surname><given-names>J. D.</given-names></name><name><surname>Sim</surname><given-names>M.</given-names></name><name><surname>Anderson</surname><given-names>M. A.</given-names></name><name><surname>Ahn</surname><given-names>S.</given-names></name><name><surname>Hannan</surname><given-names>R. D.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>ATRX interacts with H3.3 in maintaining telomere structural integrity in pluripotent embryonic stem cells.</article-title>
<source/><italic>Genome Res.</italic>
<volume>20</volume>
<fpage>351</fpage>–<lpage>360</lpage>. <pub-id pub-id-type="doi">10.1101/gr.101477.109</pub-id>
<pub-id pub-id-type="pmid">20110566</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>L. H.</given-names></name><name><surname>Ren</surname><given-names>H.</given-names></name><name><surname>Williams</surname><given-names>E.</given-names></name><name><surname>McGhie</surname><given-names>J.</given-names></name><name><surname>Ann</surname><given-names>S.</given-names></name><name><surname>Sim</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Histone H3.3 incorporation provides a unique and functionally essential telomeric chromatin in embryonic stem cells.</article-title>
<source/><italic>Genome Res.</italic>
<volume>19</volume>
<fpage>404</fpage>–<lpage>414</lpage>. <pub-id pub-id-type="doi">10.1101/gr.084947.108</pub-id>
<pub-id pub-id-type="pmid">19196724</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Scott</surname><given-names>P. G.</given-names></name><name><surname>Tredget</surname><given-names>E. E.</given-names></name></person-group> (<year>2007</year>). <article-title>Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis.</article-title>
<source/><italic>Stem Cells</italic>
<volume>25</volume>
<fpage>2648</fpage>–<lpage>2659</lpage>. <pub-id pub-id-type="doi">10.1634/stemcells.2007-2226</pub-id><pub-id pub-id-type="pmid">17615264</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Okano</surname><given-names>M.</given-names></name><name><surname>Nogami</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>He</surname><given-names>W. W.</given-names></name><etal></etal></person-group> (<year>1999</year>). <article-title>Cloning, expression and chromosome locations of the human DNMT3 gene family.</article-title>
<source/><italic>Gene</italic>
<volume>236</volume>
<fpage>87</fpage>–<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1016/S0378-1119(99)00252-258</pub-id><pub-id pub-id-type="pmid">10433969</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>Y.</given-names></name><name><surname>Gibbons</surname><given-names>R.</given-names></name><name><surname>Yan</surname><given-names>Z.</given-names></name><name><surname>Yang</surname><given-names>D.</given-names></name><name><surname>McDowell</surname><given-names>T. L.</given-names></name><name><surname>Sechi</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>100</volume>
<fpage>10635</fpage>–<lpage>10640</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1937626100</pub-id>
<pub-id pub-id-type="pmid">12953102</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yadav</surname><given-names>S.</given-names></name><name><surname>Younger</surname><given-names>S. H.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Thompson-Peer</surname><given-names>K. L.</given-names></name><name><surname>Li</surname><given-names>T.</given-names></name><name><surname>Jan</surname><given-names>L. Y.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Glial ensheathment of the somatodendritic compartment regulates sensory neuron structure and activity.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>116</volume>
<fpage>5126</fpage>–<lpage>5134</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1814456116</pub-id>
<pub-id pub-id-type="pmid">30804200</pub-id></mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yip</surname><given-names>D. J.</given-names></name><name><surname>Corcoran</surname><given-names>C. P.</given-names></name><name><surname>Alvarez-Saavedra</surname><given-names>M.</given-names></name><name><surname>DeMaria</surname><given-names>A.</given-names></name><name><surname>Rennick</surname><given-names>S.</given-names></name><name><surname>Mears</surname><given-names>A. J.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Snf2l regulates foxg1-dependent progenitor cell expansion in the developing brain.</article-title>
<source/><italic>Dev. Cell</italic>
<volume>22</volume>
<fpage>871</fpage>–<lpage>878</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2012.01.020.Yip</pub-id></mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaghlool</surname><given-names>A.</given-names></name><name><surname>Halvardson</surname><given-names>J.</given-names></name><name><surname>Zhao</surname><given-names>J. J.</given-names></name><name><surname>Etemadikhah</surname><given-names>M.</given-names></name><name><surname>Kalushkova</surname><given-names>A.</given-names></name><name><surname>Konska</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>A role for the chromatin-remodeling factor BAZ1A in neurodevelopment.</article-title>
<source/><italic>Hum. Mutat.</italic>
<volume>37</volume>
<fpage>964</fpage>–<lpage>975</lpage>. <pub-id pub-id-type="doi">10.1002/humu.23034</pub-id>
<pub-id pub-id-type="pmid">27328812</pub-id></mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>R.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Bochman</surname><given-names>M. L.</given-names></name><name><surname>Zakian</surname><given-names>V. A.</given-names></name><name><surname>Ha</surname><given-names>T.</given-names></name></person-group> (<year>2014</year>). <article-title>Periodic DNA patrolling underlies diverse functions of Pif1 on R-loops and G-rich DNA.</article-title>
<source/><italic>eLife</italic>
<volume>3</volume>:<issue>e02190</issue>. <pub-id pub-id-type="doi">10.7554/elife.02190</pub-id>
<pub-id pub-id-type="pmid">24843019</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>